[
  {
    "id": 121632,
    "drug": {
      "current_status": "MARKETED",
      "id": 25674,
      "drug_code": 88072,
      "updated_date": "2025-12-03T00:32:08-05:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8259281,
          "ingredient": {
            "id": 2182,
            "ingredient_code": 27,
            "en_name": "ANASTROZOLE",
            "fr_name": "Anastrozole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02395649",
      "brand_name": "PRO-ANASTROZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128681001"
    },
    "created_date": "2020-08-03T15:34:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02395649",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "L02BG",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "estimated_end_date": "2020-09-17T00:00:00-04:00",
    "actual_start_date": "2020-08-03T00:00:00-04:00",
    "actual_end_date": "2020-09-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-09-12T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ANASTROZOLE",
    "en_drug_common_name": "ANASTROZOLE",
    "fr_drug_brand_name": "ANASTROZOLE",
    "fr_drug_common_name": "ANASTROZOLE",
    "en_ingredients": "ANASTROZOLE",
    "fr_ingredients": "Anastrozole",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121639,
    "drug": {
      "current_status": "MARKETED",
      "id": 65826,
      "drug_code": 97852,
      "updated_date": "2025-05-15T02:37:52-04:00",
      "company": {
        "id": 10746,
        "created_date": "2018-12-05T03:00:09-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 17380,
        "mfr_code": "",
        "name": "NORA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1565 LIONEL-BOULET BLVD.",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "VARENNES",
        "postal_code": "J3X 1P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8264098,
          "ingredient": {
            "id": 668,
            "ingredient_code": 11168,
            "en_name": "SERTRALINE",
            "fr_name": "Sertraline (Chlorhydrate de sertraline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02488434",
      "brand_name": "NRA-SERTRALINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123417003"
    },
    "created_date": "2020-08-03T18:40:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02488434",
    "company_name": "NORA PHARMA INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2020-10-31T00:00:00-04:00",
    "actual_start_date": "2020-08-01T00:00:00-04:00",
    "actual_end_date": "2020-12-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-03-17T14:18:48-04:00",
    "status": "resolved",
    "en_drug_brand_name": "NRA-SERTRALINE",
    "en_drug_common_name": "SERTRALINE",
    "fr_drug_brand_name": "NRA-SERTRALINE",
    "fr_drug_common_name": "SERTRALINE",
    "en_ingredients": "SERTRALINE",
    "fr_ingredients": "SERTRALINE",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121647,
    "drug": {
      "current_status": "MARKETED",
      "id": 10850,
      "drug_code": 66737,
      "updated_date": "2025-12-03T00:30:46-05:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254096,
          "ingredient": {
            "id": 2690,
            "ingredient_code": 11188,
            "en_name": "MIDAZOLAM",
            "fr_name": "Midazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02242905",
      "brand_name": "MIDAZOLAM INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "MULTI-DOSE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119935001"
    },
    "created_date": "2020-08-04T13:04:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242905",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "N05CD",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "anticipated_start_date": "2020-08-04T00:00:00-04:00",
    "estimated_end_date": "2020-09-15T00:00:00-04:00",
    "actual_end_date": "2020-09-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-19T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Fresenius Kabi Canada Ltd. regrets to advise that due to a manufacturing delay, we will be encountering a supply interruption with our C410202 Midazolam Injection 5 mg/mL, MD Vial, 2 mL.\r\n\r\nOur C410210 Midazolam Injection 5 mg/mL, MD Vial, 10 mL format is available for substitution. Allocations for this code have been increased to cover the 2 mL demand.\r\n\r\nUPDATE SEP 18 2020 \r\nFresenius Kabi Canada Ltd. is pleased to advise that replenishment inventories of our Midazolam Injection, 5 mg/mL, MD Vial, 2 mL will be available at all distribution centres by Friday, September 18, 2020. Please note this product will remain on allocation. Contract customers will be allocated 100% of their historical average monthly volumes.",
    "fr_comments": "Au nom de Fresenius Kabi Canada Ltée, j’ai le regret de vous aviser qu’en raison d’un retard de fabrication, nous allons éprouver une interruption d’approvisionnement qui va toucher notre présentation de C410202 Midazolam injectable à 5 mg/mL en fioles DM de 2 mL.\r\n\r\nEn guise de substitut, nous vous proposons notre préparation de C410210 Midazolam injectable à 5 mg/mL en fioles DU de 10 mL. L’allocation pour ce code a été haussée pour couvrir la demande pour le format de 2 mL.\r\nUPDATE SEP 18 2020\r\nAu nom de Fresenius Kabi Canada Ltée, j’ai le plaisir d’annoncer que nous avons reconstitué nos stocks de Midazolam injectable à 5 mg/mL en fioles DM de 2 mL et que cette présentation du produit sera disponible auprès de tous nos centres de distribution dès ce vendredi 18 septembre 2020. Les clients contractuels se verront attribuer 100 % de leurs volumes mensuels moyens historiques.",
    "en_drug_brand_name": "MIDAZOLAM INJECTION",
    "en_drug_common_name": "Midazolam Injection",
    "fr_drug_brand_name": "Midazolam injectable",
    "fr_drug_common_name": "Midazolam injectable",
    "en_ingredients": "MIDAZOLAM",
    "fr_ingredients": "Midazolam",
    "drug_strength": "5MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse\r\nIntramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "5 mg/mL, MD Vial, 2 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121651,
    "drug": {
      "current_status": "MARKETED",
      "id": 5128,
      "drug_code": 31359,
      "updated_date": "2025-05-15T02:31:00-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252788,
          "ingredient": {
            "id": 1902,
            "ingredient_code": 7387,
            "en_name": "VASOPRESSIN",
            "fr_name": "Vasopressine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02139502",
      "brand_name": "VASOPRESSIN INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "F8594",
      "number_of_ais": "1",
      "ai_group_no": "0106469001"
    },
    "created_date": "2020-08-04T13:07:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02139502",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "H01BA",
    "atc_description": "POSTERIOR PITUITARY LOBE HORMONES",
    "estimated_end_date": "2021-01-31T00:00:00-05:00",
    "actual_start_date": "2020-08-04T00:00:00-04:00",
    "actual_end_date": "2021-01-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-01-26T19:56:44-05:00",
    "status": "resolved",
    "en_comments": "Fresenius Kabi Canada Ltd. regrets to advise that due to manufacturing constraints related to the Active Pharmaceutical Ingredient (API), we will be placing our Vasopressin Injection, 20 units/ mL, 1 mL MD Vials on reduced allocation. Contract customers will be allocated 50% of their historical average monthly volumes, effective August 3, 2020\r\n\r\n(UPDATE 09/01/2020) Fresenius Kabi Canada Ltd. regrets to advise that due to manufacturing constraints related to the Active Pharmaceutical Ingredient (API), we will be placing our Vasopressin Injection, 20 units/ mL, MD Vial, 1 mL on reduced allocation. Contract customers will be allocated 25% of their historical average monthly volumes, effective September 1, 2020.\r\n\r\nUPDATE 12/03: Estimated Availability Date December 21, 2020\r\n\r\nUPDATE 12/13: Estimated Availability Date January 2021\r\n(exact date: TBA)\r\nUPDATE \r\nFresenius Kabi Canada Ltd. is pleased to advise that replenishment inventories of our Vasopressin\r\nInjection 20 units/mL MD Vial 1 mL are expected to be available by January 4, 2021 for the Ontario\r\nregion and between January 6 – 8, 2021 for all other regions. Fresenius Kabi recognizes the critical\r\nneed for this product and has been working diligently to resolve the situation and resupply the market as\r\nexpeditiously as possible. Allocations for Vasopressin Injection will be set at 200% based on historical\r\ndemand to allow customers to replenish depleted safety stock levels.",
    "fr_comments": "Au nom de Fresenius Kabi Canada Ltée, j’ai le regret de vous aviser qu’en raison de contraintes de fabrication liées à l’ingrédient pharmaceutique actif (IPA), nous devons mettre sous allocation réduite notre présentation de Vasopressine injectable, 20 unités/mL, en fioles DM de 1 mL. Les clients contractuels s’en verront attribuer 50 % de leurs volumes mensuels moyens historiques, et ce, dès le 3 août 2020\r\n\r\n(UPDATE 09/01/2020) Au nom de Fresenius Kabi Canada Ltée, j’ai le regret de vous aviser qu’en raison de contraintes de fabrication liées à l’ingrédient pharmaceutique actif (IPA), nous allons mettre sous allocation réduite notre présentation de Vasopressine injectable, 20 unités/mL, en fioles DM de 1 mL. Les clients contractuels se verront attribuer 25 % de leurs volumes mensuels moyens historiques, et ce, dès le 1er septembre 2020.\r\n\r\nUPDATE 12/03: Date estimative de disponibilité 21 décembre 2020\r\n\r\nUPDATE 12/13: Date estimative de disponibilité Janvier 2021\r\n(date exacte : à confirmer)\r\n\r\nUPDATE\r\nAu nom de Fresenius Kabi Canada Ltée, j’ai le plaisir de vous annoncer que les stocks de\r\nréapprovisionnement de notre présentation de Vasopressine injectable à 20 unités/mL en fioles DM\r\nde 1 mL devraient être disponibles d’ici le 4 janvier 2021 pour la région de l’Ontario et entre le 6 et le\r\n8 janvier 2021 pour toutes les autres régions. Fresenius Kabi reconnaît le besoin critique de ce produit et\r\na travaillé avec diligence pour résoudre la situation et réapprovisionner le marché aussi rapidement que\r\npossible. Les allocations pour la Vasopressine injectable seront fixées à 200 % en fonction de la\r\ndemande historique afin de permettre aux clients de reconstituer les niveaux épuisés de stocks de\r\nsécurité.",
    "en_drug_brand_name": "VASOPRESSIN INJECTION",
    "en_drug_common_name": "Vasopressin Injection",
    "fr_drug_brand_name": "Vasopressine injectable",
    "fr_drug_common_name": "Vasopressine injectable",
    "en_ingredients": "VASOPRESSIN",
    "fr_ingredients": "Vasopressine",
    "drug_strength": "20UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intramusculaire\r\nSous-cutanée\r\nIntramusculaire\r\nSous-cutanée",
    "drug_package_quantity": "20 units/ mL, MD Vial,1 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121654,
    "drug": {
      "current_status": "MARKETED",
      "id": 20864,
      "drug_code": 82775,
      "updated_date": "2025-05-15T02:32:36-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8257382,
          "ingredient": {
            "id": 3156,
            "ingredient_code": 13346,
            "en_name": "ELETRIPTAN",
            "fr_name": "Élétriptan (Bromhydrate d'élétriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02342243",
      "brand_name": "MYLAN-ELETRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150241002"
    },
    "created_date": "2020-08-04T13:53:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02342243",
    "company_name": "UPJOHN CANADA ULC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "anticipated_start_date": "2020-08-17T00:00:00-04:00",
    "actual_end_date": "2020-09-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-09-22T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "GD-ELETRIPTAN",
    "en_drug_common_name": "GD-ELETRIPTAN",
    "fr_drug_brand_name": "GD-ELETRIPTAN",
    "fr_drug_common_name": "GD-ELETRIPTAN",
    "en_ingredients": "ELETRIPTAN",
    "fr_ingredients": "ELETRIPTAN",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "6",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121685,
    "drug": {
      "current_status": "MARKETED",
      "id": 3952,
      "drug_code": 19599,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252520,
          "ingredient": {
            "id": 1414,
            "ingredient_code": 5325,
            "en_name": "LEVOTHYROXINE SODIUM",
            "fr_name": "Lévothyroxine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "88",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02172097",
      "brand_name": "SYNTHROID",
      "brand_name_fr": "",
      "descriptor": "TAB 88MCG",
      "pediatric_flag": false,
      "accession_number": "81896",
      "number_of_ais": "1",
      "ai_group_no": "0107794027"
    },
    "created_date": "2020-08-04T17:11:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02172097",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "H03AA",
    "atc_description": "THYROID PREPARATIONS",
    "anticipated_start_date": "2020-08-14T00:00:00-04:00",
    "estimated_end_date": "2020-09-29T00:00:00-04:00",
    "actual_start_date": "2020-08-14T00:00:00-04:00",
    "actual_end_date": "2020-09-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-29T14:31:31-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SYNTHROID",
    "en_drug_common_name": "LEVOTHYROXINE",
    "fr_drug_brand_name": "SYNTHROID",
    "fr_drug_common_name": "LEVOTHYROXINE",
    "en_ingredients": "LEVOTHYROXINE SODIUM",
    "fr_ingredients": "Lévothyroxine sodique",
    "drug_strength": "88MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90BT, 1000BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121688,
    "drug": {
      "current_status": "MARKETED",
      "id": 4400,
      "drug_code": 211,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250131,
          "ingredient": {
            "id": 444,
            "ingredient_code": 9471,
            "en_name": "LIDOCAINE",
            "fr_name": "Lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00001961",
      "brand_name": "XYLOCAINE OINTMENT 5%",
      "brand_name_fr": "XYLOCAINE EN POMMADE 5%",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "07365",
      "number_of_ais": "1",
      "ai_group_no": "0103565001"
    },
    "created_date": "2020-08-04T17:47:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00001961",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "D04AB",
    "atc_description": "ANTIPRURITICS,INCL ANTIHIST,ANESTHET,ETC.",
    "anticipated_start_date": "2020-08-19T00:00:00-04:00",
    "estimated_end_date": "2020-09-11T00:00:00-04:00",
    "actual_start_date": "2020-08-21T00:00:00-04:00",
    "actual_end_date": "2020-09-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-09-14T20:04:27-04:00",
    "status": "resolved",
    "en_drug_brand_name": "XYLOCAINE OINTMENT 5%",
    "en_drug_common_name": "lidocaine 5% Ointment 35g Aluminum Tube",
    "fr_drug_brand_name": "XYLOCAINE 5% ointment",
    "fr_drug_common_name": "lidocaine 5% Ointment 35g Aluminum Tube",
    "en_ingredients": "LIDOCAINE",
    "fr_ingredients": "Lidocaïne",
    "drug_strength": "5%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "1 Tube",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121691,
    "drug": {
      "current_status": "MARKETED",
      "id": 8428,
      "drug_code": 587,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250159,
          "ingredient": {
            "id": 164,
            "ingredient_code": 10225,
            "en_name": "LIDOCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00036641",
      "brand_name": "XYLOCAINE 2%",
      "brand_name_fr": "",
      "descriptor": "2ML, 5ML, 10ML SINGLE USE AMPOULES",
      "pediatric_flag": false,
      "accession_number": "23888",
      "number_of_ais": "1",
      "ai_group_no": "0101280001"
    },
    "created_date": "2020-08-04T17:49:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00036641",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2020-08-17T00:00:00-04:00",
    "estimated_end_date": "2020-08-27T00:00:00-04:00",
    "actual_start_date": "2020-08-11T00:00:00-04:00",
    "actual_end_date": "2020-08-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-08-28T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "XYLOCAINE 2%",
    "en_drug_common_name": "lidocaine HCI 2% Plain 50x2mL SU Polyamp® Duofit®",
    "fr_drug_brand_name": "Xylocaine 2% 50x2mL",
    "fr_drug_common_name": "lidocaine HCI 2% Plain 50x2mL SU Polyamp® Duofit®",
    "en_ingredients": "LIDOCAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de lidocaïne",
    "drug_strength": "20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION\r\nBLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration\r\nBloc/Infiltration",
    "drug_package_quantity": "50x2mL SU Polyamp® Duofit®",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121702,
    "drug": {
      "current_status": "MARKETED",
      "id": 5544,
      "drug_code": 36945,
      "updated_date": "2025-12-03T00:30:35-05:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252868,
          "ingredient": {
            "id": 1414,
            "ingredient_code": 5325,
            "en_name": "LEVOTHYROXINE SODIUM",
            "fr_name": "Lévothyroxine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02213192",
      "brand_name": "ELTROXIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H4371",
      "number_of_ais": "1",
      "ai_group_no": "0107794001"
    },
    "created_date": "2020-08-04T19:38:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02213192",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "H03AA",
    "atc_description": "THYROID PREPARATIONS",
    "estimated_end_date": "2020-08-27T00:00:00-04:00",
    "actual_start_date": "2020-08-04T00:00:00-04:00",
    "actual_end_date": "2020-08-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-08-27T15:52:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ELTROXIN",
    "en_drug_common_name": "ELTROXIN 50mcg 500 Tabs",
    "fr_drug_brand_name": "ELTROXIN",
    "fr_drug_common_name": "ELTROXIN 50mcg 500 TABLETS",
    "en_ingredients": "LEVOTHYROXINE SODIUM",
    "fr_ingredients": "Lévothyroxine sodique",
    "drug_strength": "50MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 Tablets",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121768,
    "drug": {
      "current_status": "MARKETED",
      "id": 23374,
      "drug_code": 85968,
      "updated_date": "2025-12-03T00:31:50-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8258439,
          "ingredient": {
            "id": 2182,
            "ingredient_code": 27,
            "en_name": "ANASTROZOLE",
            "fr_name": "Anastrozole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02374420",
      "brand_name": "APO-ANASTROZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128681001"
    },
    "created_date": "2020-08-05T12:38:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02374420",
    "company_name": "APOTEX INC",
    "atc_number": "L02BG",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "estimated_end_date": "2020-09-25T00:00:00-04:00",
    "actual_start_date": "2020-08-03T00:00:00-04:00",
    "actual_end_date": "2020-09-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-14T13:09:38-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ANASTROZOLE",
    "en_drug_common_name": "ANASTROZOLE",
    "fr_drug_brand_name": "APO-ANASTROZOLE",
    "fr_drug_common_name": "ANASTROZOLE",
    "en_ingredients": "ANASTROZOLE",
    "fr_ingredients": "Anastrozole",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121777,
    "drug": {
      "current_status": "MARKETED",
      "id": 24494,
      "drug_code": 87109,
      "updated_date": "2025-12-03T00:31:59-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258844,
          "ingredient": {
            "id": 2674,
            "ingredient_code": 1400,
            "en_name": "AMIODARONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amiodarone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02385465",
      "brand_name": "AMIODARONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118593001"
    },
    "created_date": "2020-08-05T13:59:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02385465",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C01BD",
    "atc_description": "ANTIARRHYTHMICS, CLASS I AND III",
    "anticipated_start_date": "2020-08-24T00:00:00-04:00",
    "estimated_end_date": "2020-11-30T00:00:00-05:00",
    "actual_start_date": "2020-09-08T00:00:00-04:00",
    "actual_end_date": "2020-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-12-03T14:03:50-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AMIODARONE",
    "en_drug_common_name": "AMIODARONE",
    "fr_drug_brand_name": "AMIODARONE",
    "fr_drug_common_name": "AMIODARONE",
    "en_ingredients": "AMIODARONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'amiodarone",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121780,
    "drug": {
      "current_status": "MARKETED",
      "id": 24808,
      "drug_code": 87353,
      "updated_date": "2025-05-15T02:33:31-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258959,
          "ingredient": {
            "id": 2658,
            "ingredient_code": 11847,
            "en_name": "CITALOPRAM",
            "fr_name": "Citalopram (Bromhydrate de citalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02387964",
      "brand_name": "CITALOPRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136243002"
    },
    "created_date": "2020-08-05T14:01:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02387964",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2020-10-15T00:00:00-04:00",
    "estimated_end_date": "2020-11-01T00:00:00-04:00",
    "actual_end_date": "2020-10-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-10-16T19:10:46-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "CITALOPRAM",
    "en_drug_common_name": "CITALOPRAM",
    "fr_drug_brand_name": "CITALOPRAM",
    "fr_drug_common_name": "CITALOPRAM",
    "en_ingredients": "CITALOPRAM",
    "fr_ingredients": "CITALOPRAM",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121784,
    "drug": {
      "current_status": "MARKETED",
      "id": 30996,
      "drug_code": 93131,
      "updated_date": "2025-05-15T02:35:06-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261454,
          "ingredient": {
            "id": 3178,
            "ingredient_code": 13366,
            "en_name": "MEMANTINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de mémantine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02446049",
      "brand_name": "MEMANTINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150423001"
    },
    "created_date": "2020-08-05T14:03:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02446049",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N06DX",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "anticipated_start_date": "2020-10-26T00:00:00-04:00",
    "estimated_end_date": "2021-03-01T00:00:00-05:00",
    "actual_start_date": "2020-10-26T00:00:00-04:00",
    "actual_end_date": "2021-03-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-03-02T21:30:22-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MEMANTINE",
    "en_drug_common_name": "MEMANTINE",
    "fr_drug_brand_name": "MEMANTINE",
    "fr_drug_common_name": "MEMANTINE",
    "en_ingredients": "MEMANTINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de mémantine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121787,
    "drug": {
      "current_status": "MARKETED",
      "id": 28026,
      "drug_code": 90201,
      "updated_date": "2025-12-03T00:32:26-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260192,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02417383",
      "brand_name": "QUETIAPINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858005"
    },
    "created_date": "2020-08-05T14:05:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02417383",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2020-08-31T00:00:00-04:00",
    "estimated_end_date": "2020-09-25T00:00:00-04:00",
    "actual_end_date": "2020-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-10-09T20:00:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "QUETIAPINE XR",
    "en_drug_common_name": "QUETIAPINE XR",
    "fr_drug_brand_name": "QUETIAPINE XR",
    "fr_drug_common_name": "QUETIAPINE XR",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE XR",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121825,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10924,
      "drug_code": 6686,
      "updated_date": "2025-05-15T03:30:18-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8280892,
          "ingredient": {
            "id": 206,
            "ingredient_code": 8618,
            "en_name": "ERYTHROMYCIN",
            "fr_name": "Érythromycine (Stéarate d'érythromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00637416",
      "brand_name": "ERYTHRO-ES",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "63845",
      "number_of_ais": "1",
      "ai_group_no": "0105708012"
    },
    "created_date": "2020-08-06T13:38:12-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00637416",
    "company_name": "AA PHARMA INC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "discontinuation_date": "2019-01-15T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-08-06T13:39:55-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "ERYTHRO-ES",
    "en_drug_common_name": "Erythromycin tablet",
    "fr_drug_brand_name": "ERYTHRO-ES",
    "fr_drug_common_name": "Érythromycine Comprimé",
    "en_ingredients": "ERYTHROMYCIN",
    "fr_ingredients": "Érythromycine",
    "drug_strength": "600MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121828,
    "drug": {
      "current_status": "DORMANT",
      "id": 12166,
      "drug_code": 70218,
      "updated_date": "2025-05-15T06:55:30-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8367562,
          "ingredient": {
            "id": 1298,
            "ingredient_code": 1945,
            "en_name": "IPRATROPIUM BROMIDE",
            "fr_name": "Bromure d'ipratropium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "21",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02246083",
      "brand_name": "IPRAVENT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115643002"
    },
    "created_date": "2020-08-06T13:42:10-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02246083",
    "company_name": "AA PHARMA INC",
    "atc_number": "R01AX",
    "atc_description": "DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE",
    "discontinuation_date": "2017-07-28T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-08-06T13:42:46-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "IPRAVENT",
    "en_drug_common_name": "Ipratropium bromide solution",
    "fr_drug_brand_name": "IPRAVENT",
    "fr_drug_common_name": "Bromure d'ipratropium",
    "en_ingredients": "IPRATROPIUM BROMIDE",
    "fr_ingredients": "Bromure d'ipratropium",
    "drug_strength": "21MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "NASAL",
    "drug_route_fr": "Nasale",
    "drug_package_quantity": "15 mL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121831,
    "drug": {
      "current_status": "DORMANT",
      "id": 66,
      "drug_code": 10136,
      "updated_date": "2025-05-15T06:55:23-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366566,
          "ingredient": {
            "id": 66,
            "ingredient_code": 2327,
            "en_name": "KETOPROFEN",
            "fr_name": "Kétoprofène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00790427",
      "brand_name": "KETOPROFEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69838",
      "number_of_ais": "1",
      "ai_group_no": "0110497001"
    },
    "created_date": "2020-08-06T13:44:23-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00790427",
    "company_name": "AA PHARMA INC",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "discontinuation_date": "2019-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-08-06T13:45:08-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "KETOPROFEN",
    "en_drug_common_name": "Ketoprofen capsule",
    "fr_drug_brand_name": "Ketoprofen",
    "fr_drug_common_name": "Ketoprofen capsule",
    "en_ingredients": "KETOPROFEN",
    "fr_ingredients": "Kétoprofène",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121834,
    "drug": {
      "current_status": "DORMANT",
      "id": 4376,
      "drug_code": 2058,
      "updated_date": "2025-05-15T06:55:19-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366004,
          "ingredient": {
            "id": 1682,
            "ingredient_code": 7944,
            "en_name": "PIMOZIDE",
            "fr_name": "Pimozide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00313815",
      "brand_name": "ORAP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "46978",
      "number_of_ais": "1",
      "ai_group_no": "0109963001"
    },
    "created_date": "2020-08-06T13:46:38-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00313815",
    "company_name": "AA PHARMA INC",
    "atc_number": "N05AG",
    "atc_description": "ANTIPSYCHOTICS",
    "discontinuation_date": "2017-07-28T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-08-06T13:47:08-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "ORAP",
    "en_drug_common_name": "PIMOZIDE tablet",
    "fr_drug_brand_name": "Orap",
    "fr_drug_common_name": "PIMOZIDE",
    "en_ingredients": "PIMOZIDE",
    "fr_ingredients": "Pimozide",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121837,
    "drug": {
      "current_status": "DORMANT",
      "id": 4378,
      "drug_code": 2059,
      "updated_date": "2025-05-15T06:55:19-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366005,
          "ingredient": {
            "id": 1682,
            "ingredient_code": 7944,
            "en_name": "PIMOZIDE",
            "fr_name": "Pimozide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00313823",
      "brand_name": "ORAP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "46979",
      "number_of_ais": "1",
      "ai_group_no": "0109963003"
    },
    "created_date": "2020-08-06T13:48:05-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00313823",
    "company_name": "AA PHARMA INC",
    "atc_number": "N05AG",
    "atc_description": "ANTIPSYCHOTICS",
    "discontinuation_date": "2017-07-28T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-08-06T13:48:26-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "ORAP",
    "en_drug_common_name": "PIMOZIDE",
    "fr_drug_brand_name": "Orap",
    "fr_drug_common_name": "PIMOZIDE",
    "en_ingredients": "PIMOZIDE",
    "fr_ingredients": "Pimozide",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121840,
    "drug": {
      "current_status": "MARKETED",
      "id": 25590,
      "drug_code": 88000,
      "updated_date": "2025-05-15T02:33:42-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8259247,
          "ingredient": {
            "id": 2926,
            "ingredient_code": 12371,
            "en_name": "ESOMEPRAZOLE",
            "fr_name": "Ésoméprazole (Ésoméprazole magnésien dihydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02394847",
      "brand_name": "ESOMEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0145162002"
    },
    "created_date": "2020-08-06T14:01:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02394847",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2021-08-30T00:00:00-04:00",
    "actual_start_date": "2020-08-10T00:00:00-04:00",
    "actual_end_date": "2021-08-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-08-28T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ESOMEPRAZOLE",
    "en_drug_common_name": "ESOMEPRAZOLE",
    "fr_drug_brand_name": "ESOMEPRAZOLE",
    "fr_drug_common_name": "ESOMEPRAZOLE",
    "en_ingredients": "ESOMEPRAZOLE",
    "fr_ingredients": "ESOMEPRAZOLE",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30,500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121843,
    "drug": {
      "current_status": "MARKETED",
      "id": 1158,
      "drug_code": 12662,
      "updated_date": "2025-05-15T02:30:53-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251655,
          "ingredient": {
            "id": 668,
            "ingredient_code": 11168,
            "en_name": "SERTRALINE",
            "fr_name": "Sertraline (Chlorhydrate de sertraline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01962817",
      "brand_name": "ZOLOFT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "73830",
      "number_of_ais": "1",
      "ai_group_no": "0123417001"
    },
    "created_date": "2020-08-06T14:25:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01962817",
    "company_name": "UPJOHN CANADA ULC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "actual_start_date": "2020-08-05T00:00:00-04:00",
    "actual_end_date": "2020-11-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-11-06T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ZOLOFT",
    "en_drug_common_name": "ZOLOFT",
    "fr_drug_brand_name": "ZOLOFT",
    "fr_drug_common_name": "ZOLOFT",
    "en_ingredients": "SERTRALINE",
    "fr_ingredients": "SERTRALINE",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "250",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121852,
    "drug": {
      "current_status": "MARKETED",
      "id": 18906,
      "drug_code": 80161,
      "updated_date": "2025-05-15T02:32:14-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256602,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02316080",
      "brand_name": "ACT QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858001"
    },
    "created_date": "2020-08-06T14:59:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02316080",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2020-12-31T00:00:00-05:00",
    "actual_start_date": "2020-08-05T00:00:00-04:00",
    "actual_end_date": "2021-01-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-01-07T18:19:26-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT QUETIAPINE",
    "en_drug_common_name": "QUETIAPINE 25MG FC TAB",
    "fr_drug_brand_name": "ACT-QUETIAPINE 25MG FC TAB",
    "fr_drug_common_name": "QUETIAPINE 25MG FC TAB",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121855,
    "drug": {
      "current_status": "MARKETED",
      "id": 18836,
      "drug_code": 80098,
      "updated_date": "2025-12-03T00:31:21-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256584,
          "ingredient": {
            "id": 3084,
            "ingredient_code": 11705,
            "en_name": "LEVOFLOXACIN",
            "fr_name": "Lévofloxacine (Hémihydrate de lévofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "750",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02315440",
      "brand_name": "TEVA-LEVOFLOXACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131663005"
    },
    "created_date": "2020-08-06T15:01:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02315440",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01MA",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "estimated_end_date": "2020-08-31T00:00:00-04:00",
    "actual_start_date": "2020-08-05T00:00:00-04:00",
    "actual_end_date": "2020-08-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-08-27T18:56:51-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT LEVOFLOXACIN",
    "en_drug_common_name": "LEVOFLOXACIN 750MG FC TAB",
    "fr_drug_brand_name": "ACT-LEVOFLOXACIN 750MG FC TAB",
    "fr_drug_common_name": "LEVOFLOXACIN 750MG FC TAB",
    "en_ingredients": "LEVOFLOXACIN",
    "fr_ingredients": "Lévofloxacine",
    "drug_strength": "750MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121862,
    "drug": {
      "current_status": "MARKETED",
      "id": 30560,
      "drug_code": 92603,
      "updated_date": "2025-05-15T02:34:48-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261210,
          "ingredient": {
            "id": 3162,
            "ingredient_code": 13352,
            "en_name": "CINACALCET",
            "fr_name": "Cinacalcet (Chlorhydrate de cinacalcet)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "90",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02441640",
      "brand_name": "TEVA-CINACALCET",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150282003"
    },
    "created_date": "2020-08-06T17:26:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02441640",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "H05BX",
    "atc_description": "ANTI-PARATHYROID HORMONES",
    "actual_start_date": "2020-08-05T00:00:00-04:00",
    "actual_end_date": "2021-03-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-04-01T17:56:53-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CINACALCET",
    "en_drug_common_name": "CINACALCET 90MG TAB",
    "fr_drug_brand_name": "TEVA-CINACALCET 90MG TAB",
    "fr_drug_common_name": "CINACALCET 90MG TAB",
    "en_ingredients": "CINACALCET",
    "fr_ingredients": "CINACALCET",
    "drug_strength": "90MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121865,
    "drug": {
      "current_status": "MARKETED",
      "id": 4044,
      "drug_code": 19756,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252566,
          "ingredient": {
            "id": 1604,
            "ingredient_code": 5895,
            "en_name": "VINCRISTINE SULFATE",
            "fr_name": "Sulfate de vincristine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02143305",
      "brand_name": "VINCRISTINE SULFATE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82052",
      "number_of_ais": "1",
      "ai_group_no": "0107646001"
    },
    "created_date": "2020-08-06T17:29:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02143305",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L01CA",
    "atc_description": "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",
    "estimated_end_date": "2020-11-30T00:00:00-05:00",
    "actual_start_date": "2020-08-05T00:00:00-04:00",
    "actual_end_date": "2020-11-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-07T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VINCRISTINE SULFATE INJECTION",
    "en_drug_common_name": "VINCRISTINE INJECTION 1MG/ML",
    "fr_drug_brand_name": "VINCRISTINE INJECTION 1MG/ML",
    "fr_drug_common_name": "VINCRISTINE INJECTION 1MG/ML",
    "en_ingredients": "VINCRISTINE SULFATE",
    "fr_ingredients": "Sulfate de vincristine",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121885,
    "drug": {
      "current_status": "MARKETED",
      "id": 13662,
      "drug_code": 73499,
      "updated_date": "2025-05-15T02:31:34-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254932,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02250187",
      "brand_name": "TEVA-SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415005"
    },
    "created_date": "2020-08-06T18:22:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02250187",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "actual_start_date": "2020-08-05T00:00:00-04:00",
    "actual_end_date": "2021-04-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-04-15T19:07:30-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-SIMVASTATIN",
    "en_drug_common_name": "SIMVASTATIN 80MG TABS",
    "fr_drug_brand_name": "TEVA-SIMVASTATIN 80MG TABS",
    "fr_drug_common_name": "SIMVASTATIN 80MG TABS",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "P PACK 30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121888,
    "drug": {
      "current_status": "MARKETED",
      "id": 32168,
      "drug_code": 9887,
      "updated_date": "2025-05-15T02:30:48-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251237,
          "ingredient": {
            "id": 1350,
            "ingredient_code": 2167,
            "en_name": "METOPROLOL TARTRATE",
            "fr_name": "Tartrate de métoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00842656",
      "brand_name": "TEVA-METOPROLOL",
      "brand_name_fr": "",
      "descriptor": "UNCOATED",
      "pediatric_flag": false,
      "accession_number": "69243",
      "number_of_ais": "1",
      "ai_group_no": "0111923003"
    },
    "created_date": "2020-08-06T18:23:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00842656",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "actual_start_date": "2020-08-05T00:00:00-04:00",
    "actual_end_date": "2021-03-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-03-25T15:25:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-METOPROLOL",
    "en_drug_common_name": "METOPROLOL 100MG UNCOAT TAB",
    "fr_drug_brand_name": "TEVA-METOPROLOL 100MG UNCOAT TAB",
    "fr_drug_common_name": "METOPROLOL 100MG UNCOAT TAB",
    "en_ingredients": "METOPROLOL TARTRATE",
    "fr_ingredients": "Tartrate de métoprolol",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121891,
    "drug": {
      "current_status": "MARKETED",
      "id": 51287,
      "drug_code": 94919,
      "updated_date": "2025-05-15T02:35:45-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262353,
          "ingredient": {
            "id": 3356,
            "ingredient_code": 20022,
            "en_name": "DEFERASIROX",
            "fr_name": "Déférasirox"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02461552",
      "brand_name": "APO-DEFERASIROX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151733002"
    },
    "created_date": "2020-08-06T18:55:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02461552",
    "company_name": "APOTEX INC",
    "atc_number": "V03AC",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "estimated_end_date": "2020-11-20T00:00:00-05:00",
    "actual_start_date": "2020-08-03T00:00:00-04:00",
    "actual_end_date": "2020-11-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-28T06:00:01-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DEFERASIROX",
    "en_drug_common_name": "DEFERASIROX",
    "fr_drug_brand_name": "APO-DEFERASIROX",
    "fr_drug_common_name": "DEFERASIROX",
    "en_ingredients": "DEFERASIROX",
    "fr_ingredients": "Déférasirox",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET FOR SUSPENSION",
    "drug_dosage_form_fr": "Comprimé pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121894,
    "drug": {
      "current_status": "MARKETED",
      "id": 32,
      "drug_code": 10037,
      "updated_date": "2025-05-15T02:30:49-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8251277,
          "ingredient": {
            "id": 42,
            "ingredient_code": 2013,
            "en_name": "DICLOFENAC SODIUM",
            "fr_name": "Diclofénac sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00839183",
      "brand_name": "APO-DICLO",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69682",
      "number_of_ais": "1",
      "ai_group_no": "0114417002"
    },
    "created_date": "2020-08-06T18:57:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00839183",
    "company_name": "APOTEX INC",
    "atc_number": "M01AB",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2020-10-02T00:00:00-04:00",
    "actual_start_date": "2020-08-03T00:00:00-04:00",
    "actual_end_date": "2020-09-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-28T15:09:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DICLO",
    "en_drug_common_name": "DICLO",
    "fr_drug_brand_name": "APO-DICLO",
    "fr_drug_common_name": "DICLO",
    "en_ingredients": "DICLOFENAC SODIUM",
    "fr_ingredients": "Diclofénac sodique",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121897,
    "drug": {
      "current_status": "MARKETED",
      "id": 7548,
      "drug_code": 50278,
      "updated_date": "2025-12-03T00:30:39-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253337,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "120",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02230997",
      "brand_name": "APO-DILTIAZ CD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863004"
    },
    "created_date": "2020-08-06T19:01:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230997",
    "company_name": "APOTEX INC",
    "atc_number": "C08DB",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "estimated_end_date": "2020-11-27T00:00:00-05:00",
    "actual_start_date": "2020-08-03T00:00:00-04:00",
    "actual_end_date": "2020-11-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-23T14:00:54-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DILTIAZ CD",
    "en_drug_common_name": "DILTIAZ",
    "fr_drug_brand_name": "APO-DILTIAZ CD",
    "fr_drug_common_name": "DILTIAZ",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "120MG",
    "drug_dosage_form": "CAPSULE (CONTROLLED-DELIVERY)\r\nCAPSULE (CONTROLLED-DELIVERY)",
    "drug_dosage_form_fr": "Capsule (à libération contrôlée)\r\nCapsule (à libération contrôlée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121903,
    "drug": {
      "current_status": "MARKETED",
      "id": 31558,
      "drug_code": 93875,
      "updated_date": "2025-05-15T02:35:17-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261800,
          "ingredient": {
            "id": 610,
            "ingredient_code": 1249,
            "en_name": "FELODIPINE",
            "fr_name": "Félodipine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452367",
      "brand_name": "APO-FELODIPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121733003"
    },
    "created_date": "2020-08-06T19:17:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452367",
    "company_name": "APOTEX INC",
    "atc_number": "C08CA",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.",
    "estimated_end_date": "2020-09-03T00:00:00-04:00",
    "actual_start_date": "2020-08-03T00:00:00-04:00",
    "actual_end_date": "2020-09-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-04T18:06:42-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-FELODIPINE",
    "en_drug_common_name": "FELODIPINE",
    "fr_drug_brand_name": "APO-FELODIPINE",
    "fr_drug_common_name": "FELODIPINE",
    "en_ingredients": "FELODIPINE",
    "fr_ingredients": "Félodipine",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121906,
    "drug": {
      "current_status": "MARKETED",
      "id": 8394,
      "drug_code": 5819,
      "updated_date": "2025-05-15T02:30:35-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8250835,
          "ingredient": {
            "id": 1350,
            "ingredient_code": 2167,
            "en_name": "METOPROLOL TARTRATE",
            "fr_name": "Tartrate de métoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00618640",
      "brand_name": "APO-METOPROLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "61597",
      "number_of_ais": "1",
      "ai_group_no": "0111923003"
    },
    "created_date": "2020-08-06T19:22:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00618640",
    "company_name": "APOTEX INC",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2020-11-26T00:00:00-05:00",
    "actual_start_date": "2020-08-03T00:00:00-04:00",
    "actual_end_date": "2020-11-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-09T14:03:56-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO METOPROLOL TAB 100MG",
    "en_drug_common_name": "METOPROLOL",
    "fr_drug_brand_name": "APO-METOPROLOL",
    "fr_drug_common_name": "METOPROLOL",
    "en_ingredients": "METOPROLOL TARTRATE",
    "fr_ingredients": "Tartrate de métoprolol",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121909,
    "drug": {
      "current_status": "MARKETED",
      "id": 8016,
      "drug_code": 5222,
      "updated_date": "2025-05-15T02:30:32-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8250723,
          "ingredient": {
            "id": 1090,
            "ingredient_code": 2414,
            "en_name": "NAPROXEN",
            "fr_name": "Naproxène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00592277",
      "brand_name": "APO-NAPROXEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "60000",
      "number_of_ais": "1",
      "ai_group_no": "0109634003"
    },
    "created_date": "2020-08-06T19:27:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00592277",
    "company_name": "APOTEX INC",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2020-10-09T00:00:00-04:00",
    "actual_start_date": "2020-08-03T00:00:00-04:00",
    "actual_end_date": "2020-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-05T12:55:30-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-NAPROXEN",
    "en_drug_common_name": "NAPROXEN",
    "fr_drug_brand_name": "APO-NAPROXEN",
    "fr_drug_common_name": "NAPROXEN",
    "en_ingredients": "NAPROXEN",
    "fr_ingredients": "Naproxène",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121913,
    "drug": {
      "current_status": "MARKETED",
      "id": 15988,
      "drug_code": 76778,
      "updated_date": "2025-05-15T02:31:45-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255715,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02282119",
      "brand_name": "APO-RISPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332006"
    },
    "created_date": "2020-08-06T19:35:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02282119",
    "company_name": "APOTEX INC",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2020-11-06T00:00:00-05:00",
    "actual_start_date": "2020-08-03T00:00:00-04:00",
    "actual_end_date": "2020-11-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-09T14:15:36-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-RISPERIDONE",
    "en_drug_common_name": "RISPERIDONE",
    "fr_drug_brand_name": "APO-RISPERIDONE",
    "fr_drug_common_name": "RISPERIDONE",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121916,
    "drug": {
      "current_status": "DORMANT",
      "id": 66099,
      "drug_code": 96268,
      "updated_date": "2025-12-03T02:32:45-05:00",
      "company": {
        "id": 14455,
        "created_date": "2020-02-05T22:45:05-05:00",
        "updated_date": "2025-05-15T02:30:24-04:00",
        "company_code": 17254,
        "mfr_code": "",
        "name": "SEQIRUS PTY LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "63 POPLAR ROAD",
        "province": "VICTORIA",
        "country": "AUSTRALIA",
        "city": "PARKVILLE",
        "postal_code": "3052",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369503,
          "ingredient": {
            "id": 3954,
            "ingredient_code": 22251,
            "en_name": "HAEMAGGLUTININ-STRAIN B",
            "fr_name": "Hémagglutinine-souche B (Yamagata)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8369502,
          "ingredient": {
            "id": 3952,
            "ingredient_code": 22250,
            "en_name": "HAEMAGGLUTININ-STRAIN B",
            "fr_name": "Hémagglutinine-souche B (Victoria)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8369501,
          "ingredient": {
            "id": 2024,
            "ingredient_code": 744,
            "en_name": "HAEMAGGLUTININ-STRAIN A",
            "fr_name": "Hémagglutinine-souche A (H1N1)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8369500,
          "ingredient": {
            "id": 2022,
            "ingredient_code": 743,
            "en_name": "HAEMAGGLUTININ-STRAIN A",
            "fr_name": "Hémagglutinine-souche A (H3N2)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02473283",
      "brand_name": "AFLURIA TETRA",
      "brand_name_fr": "",
      "descriptor": "SINGLE-DOSE PREFILLED SYRINGE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "4",
      "ai_group_no": "0455410003"
    },
    "created_date": "2020-08-06T21:52:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02473283",
    "company_name": "SEQIRUS PTY LTD",
    "atc_number": "J07BB",
    "atc_description": "VIRAL VACCINES",
    "actual_start_date": "2020-09-30T00:00:00-04:00",
    "actual_end_date": "2020-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-01-27T16:48:39-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AFLURIA TETRA",
    "en_drug_common_name": "Quadrivalent Influenza Vaccine",
    "fr_drug_brand_name": "AFLURIA TETRA",
    "fr_drug_common_name": "Quadrivalent Influenza Vaccine",
    "en_ingredients": "HAEMAGGLUTININ-STRAIN A\r\nHAEMAGGLUTININ-STRAIN A\r\nHAEMAGGLUTININ-STRAIN B\r\nHAEMAGGLUTININ-STRAIN B",
    "fr_ingredients": "HAEMAGGLUTININ-STRAIN A(H1N1)  HAEMAGGLUTININ -STRAIN A(H3N2)    \r\nHAEMAGGLUTININ-STRAIN B                \r\n(VICTORIA)\r\nHAEMAGGLUTININ-STRAIN B     \r\n(YAMAGATA)",
    "drug_strength": "15MCG\r\n15MCG\r\n15MCG\r\n15MCG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INTRAMUSCULAR\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire\r\nIntramusculaire",
    "drug_package_quantity": "SINGLE-DOSE PREFILLED SYRINGE",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121934,
    "drug": {
      "current_status": "MARKETED",
      "id": 22526,
      "drug_code": 85004,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8258089,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02365197",
      "brand_name": "IRBESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700001"
    },
    "created_date": "2020-08-07T15:45:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02365197",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2020-08-19T00:00:00-04:00",
    "actual_start_date": "2020-08-07T00:00:00-04:00",
    "actual_end_date": "2020-08-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-08-20T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "IRBESARTAN",
    "en_drug_common_name": "IRBESARTAN",
    "fr_drug_brand_name": "IRBESARTAN",
    "fr_drug_common_name": "IRBESARTAN",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121940,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 31312,
      "drug_code": 93561,
      "updated_date": "2025-05-15T04:24:24-04:00",
      "company": {
        "id": 17008,
        "created_date": "2020-12-09T00:53:25-05:00",
        "updated_date": "2025-05-15T03:22:32-04:00",
        "company_code": 15921,
        "mfr_code": "",
        "name": "IBSA INSTITUT BIOCHIMIQUE SA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "VIA PIAN SCAIROLO 49",
        "province": "--",
        "country": "SWITZERLAND",
        "city": "PAZZALLO",
        "postal_code": "6912",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8356447,
          "ingredient": {
            "id": 3714,
            "ingredient_code": 13244,
            "en_name": "BETAMETHASONE VALERATE",
            "fr_name": "Valérate de bétaméthasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02449773",
      "brand_name": "BETEFLAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106302001"
    },
    "created_date": "2020-08-07T18:57:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02449773",
    "company_name": "CIPHER PHARMACEUTICALS INC",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "actual_start_date": "2020-08-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-08-08T05:00:02-04:00",
    "status": "active_confirmed",
    "en_comments": "Business partner changes resulting in disruption of distribution",
    "fr_comments": "Changements de partenaires commerciaux entraînant une interruption de la distribution",
    "en_drug_brand_name": "BETEFLAM",
    "en_drug_common_name": "BETAMETHASONE VALERATE Topical Patch",
    "fr_drug_brand_name": "BETEFLAM",
    "fr_drug_common_name": "Timbre de valérate de bétaméthasone pour usage topique",
    "en_ingredients": "BETAMETHASONE VALERATE",
    "fr_ingredients": "Valérate de bétaméthasone",
    "drug_strength": "0.1%",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "4 patches/8 patches/16 patches",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121985,
    "drug": {
      "current_status": "MARKETED",
      "id": 16312,
      "drug_code": 771,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 510,
        "created_date": "2017-03-09T13:22:50-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16647,
        "mfr_code": "",
        "name": "SEARCHLIGHT PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1600 RUE NOTRE DAME OUEST, SUITE 312",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3J 1M1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250182,
          "ingredient": {
            "id": 3106,
            "ingredient_code": 6363,
            "en_name": "ETHOSUXIMIDE",
            "fr_name": "Éthosuximide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00022799",
      "brand_name": "ZARONTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "29524",
      "number_of_ais": "1",
      "ai_group_no": "0107470002"
    },
    "created_date": "2020-08-10T16:36:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00022799",
    "company_name": "ERFA CANADA 2012 INC",
    "atc_number": "N03AD",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2020-08-03T00:00:00-04:00",
    "estimated_end_date": "2020-09-22T00:00:00-04:00",
    "actual_start_date": "2020-08-04T00:00:00-04:00",
    "actual_end_date": "2020-09-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-25T14:45:18-04:00",
    "status": "resolved",
    "en_comments": "ZARONTIN SYRUP AVAILABLE",
    "fr_comments": "ZARONTIN SYROP DISPONIBLE",
    "en_drug_brand_name": "ZARONTIN CAP 250MG",
    "en_drug_common_name": "ZARONTIN CAPSULES",
    "fr_drug_brand_name": "ZARONTIN CAP 250MG",
    "fr_drug_common_name": "ZARONTIN CAPSULES",
    "en_ingredients": "ETHOSUXIMIDE",
    "fr_ingredients": "Éthosuximide",
    "drug_strength": "250MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 TABS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121993,
    "drug": {
      "current_status": "MARKETED",
      "id": 5778,
      "drug_code": 3823,
      "updated_date": "2025-05-15T02:30:30-04:00",
      "company": {
        "id": 5980,
        "created_date": "2017-11-10T19:30:11-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17241,
        "mfr_code": "",
        "name": "ICU MEDICAL CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2600 BOUL ALFRED-NOBEL, SUITE 100",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT LAURENT",
        "postal_code": "H4S 0A9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250569,
          "ingredient": {
            "id": 162,
            "ingredient_code": 9547,
            "en_name": "MANNITOL",
            "fr_name": "Mannitol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250568,
          "ingredient": {
            "id": 778,
            "ingredient_code": 9192,
            "en_name": "SORBITOL",
            "fr_name": "Sorbitol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "27",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00498807",
      "brand_name": "SORBITOL MANNITOL IRRIGATION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "55620",
      "number_of_ais": "2",
      "ai_group_no": "0203278001"
    },
    "created_date": "2020-08-10T17:52:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00498807",
    "company_name": "ICU MEDICAL CANADA INC",
    "atc_number": "B05CX",
    "atc_description": "IRRIGATING SOLUTIONS",
    "anticipated_start_date": "2020-09-10T00:00:00-04:00",
    "estimated_end_date": "2020-11-20T00:00:00-05:00",
    "actual_end_date": "2020-11-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-25T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "This issue has been resolved.",
    "en_drug_brand_name": "SORBITOL MANNITOL IRRIGATION",
    "en_drug_common_name": "Sorbitol Mannitol Irrigation",
    "fr_drug_brand_name": "Sorbitol Mannitol Irrigation",
    "fr_drug_common_name": "Sorbitol Mannitol Irrigation",
    "en_ingredients": "SORBITOL\r\nMANNITOL",
    "fr_ingredients": "Sorbitol\r\nMannitol",
    "drug_strength": "27MG\r\n5.4MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "IRRIGATION\r\nIRRIGATION",
    "drug_route_fr": "Irrigation\r\nIrrigation",
    "drug_package_quantity": "3000 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 121996,
    "drug": {
      "current_status": "MARKETED",
      "id": 3488,
      "drug_code": 18778,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252381,
          "ingredient": {
            "id": 1476,
            "ingredient_code": 11163,
            "en_name": "TIMOLOL",
            "fr_name": "Timolol (Maléate de timolol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02171899",
      "brand_name": "TIMOPTIC-XE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81052",
      "number_of_ais": "1",
      "ai_group_no": "0131275002"
    },
    "created_date": "2020-08-10T19:44:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02171899",
    "company_name": "PURDUE PHARMA",
    "atc_number": "S01ED",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "estimated_end_date": "2020-10-06T00:00:00-04:00",
    "actual_start_date": "2020-09-08T00:00:00-04:00",
    "actual_end_date": "2020-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-10-03T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TIMOPTIC-XE",
    "en_drug_common_name": "Timoptic",
    "fr_drug_brand_name": "Timoptic XE",
    "fr_drug_common_name": "Timoptic",
    "en_ingredients": "TIMOLOL",
    "fr_ingredients": "Timolol",
    "drug_strength": "0.5%",
    "drug_dosage_form": "SOLUTION (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Solution (à libération prolongée)",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "5ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122000,
    "drug": {
      "current_status": "MARKETED",
      "id": 12674,
      "drug_code": 71466,
      "updated_date": "2025-12-03T00:30:53-05:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8254639,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247224",
      "brand_name": "PRO-SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415005"
    },
    "created_date": "2020-08-10T22:37:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247224",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2020-09-15T00:00:00-04:00",
    "actual_start_date": "2020-08-10T00:00:00-04:00",
    "actual_end_date": "2020-09-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-09-05T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SIMVASTATIN-80",
    "en_drug_common_name": "SIMVASTATIN-80",
    "fr_drug_brand_name": "SIMVASTATIN-80",
    "fr_drug_common_name": "SIMVASTATIN-80",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122005,
    "drug": {
      "current_status": "MARKETED",
      "id": 64051,
      "drug_code": 96453,
      "updated_date": "2025-12-03T00:33:45-05:00",
      "company": {
        "id": 17271,
        "created_date": "2023-06-19T22:00:15-04:00",
        "updated_date": "2025-05-15T02:30:24-04:00",
        "company_code": 18848,
        "mfr_code": "",
        "name": "BIOSIMILAR COLLABORATIONS IRELAND LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 35/36",
        "street_name": "GRANGE PARADE, BALDOYLE INDUSTRIAL ESTATE, DUBLIN 13",
        "province": "--",
        "country": "IRELAND",
        "city": "DUBLIN",
        "postal_code": "D13R20R",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263171,
          "ingredient": {
            "id": 2724,
            "ingredient_code": 11905,
            "en_name": "TRASTUZUMAB",
            "fr_name": "Trastuzumab"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02474425",
      "brand_name": "OGIVRI",
      "brand_name_fr": "",
      "descriptor": "SINGLE-DOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0154252002"
    },
    "created_date": "2020-08-11T02:45:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02474425",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "L01XC",
    "atc_description": "OTHER ANTINEOPLASTIC AGENTS",
    "estimated_end_date": "2020-08-24T00:00:00-04:00",
    "actual_start_date": "2020-08-10T00:00:00-04:00",
    "actual_end_date": "2020-08-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-08-14T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Limited product supply is available, product on allocation.",
    "fr_comments": "Limited product supply is available. product on allocation.",
    "en_drug_brand_name": "OGIVRI",
    "en_drug_common_name": "TRASTUZUMAB",
    "fr_drug_brand_name": "Ogivri",
    "fr_drug_common_name": "Trastuzumab",
    "en_ingredients": "TRASTUZUMAB",
    "fr_ingredients": "Trastuzumab",
    "drug_strength": "150MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1VL TRASTUZUMAB",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122008,
    "drug": {
      "current_status": "MARKETED",
      "id": 64053,
      "drug_code": 96454,
      "updated_date": "2025-12-03T00:33:45-05:00",
      "company": {
        "id": 17271,
        "created_date": "2023-06-19T22:00:15-04:00",
        "updated_date": "2025-05-15T02:30:24-04:00",
        "company_code": 18848,
        "mfr_code": "",
        "name": "BIOSIMILAR COLLABORATIONS IRELAND LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 35/36",
        "street_name": "GRANGE PARADE, BALDOYLE INDUSTRIAL ESTATE, DUBLIN 13",
        "province": "--",
        "country": "IRELAND",
        "city": "DUBLIN",
        "postal_code": "D13R20R",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263173,
          "ingredient": {
            "id": 2724,
            "ingredient_code": 11905,
            "en_name": "TRASTUZUMAB",
            "fr_name": "Trastuzumab"
          },
          "ingredient_supplied_ind": "I",
          "strength": "440",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        },
        {
          "id": 8263172,
          "ingredient": {
            "id": 482,
            "ingredient_code": 8826,
            "en_name": "WATER",
            "fr_name": "Eau"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "ML",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02474433",
      "brand_name": "OGIVRI",
      "brand_name_fr": "",
      "descriptor": "MULTI-DOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0238103001"
    },
    "created_date": "2020-08-11T02:49:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02474433",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "L01XC",
    "atc_description": "OTHER ANTINEOPLASTIC AGENTS",
    "estimated_end_date": "2020-08-24T00:00:00-04:00",
    "actual_start_date": "2020-08-10T00:00:00-04:00",
    "actual_end_date": "2020-08-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-08-14T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Limited product supply is available, product on allocation.",
    "fr_comments": "Limited product supply is available, product on allocation.",
    "en_drug_brand_name": "OGIVRI",
    "en_drug_common_name": "TRASTUZUMAB",
    "fr_drug_brand_name": "Ogivri",
    "fr_drug_common_name": "Trastuzumab",
    "en_ingredients": "TRASTUZUMAB\r\nWATER",
    "fr_ingredients": "Trastuzumab\r\nEau",
    "drug_strength": "440MG\r\n20ML",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1VL TRASTUZUMAB 1VL BWFI",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122033,
    "drug": {
      "current_status": "MARKETED",
      "id": 21528,
      "drug_code": 83912,
      "updated_date": "2025-05-15T02:32:46-04:00",
      "company": {
        "id": 678,
        "created_date": "2017-03-09T13:23:04-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 14108,
        "mfr_code": "",
        "name": "TAKEDA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "3800",
        "street_name": "22 ADELAIDE STREET WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5H 4E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257689,
          "ingredient": {
            "id": 2122,
            "ingredient_code": 96,
            "en_name": "ANTI-INHIBITOR COAGULANT COMPLEX",
            "fr_name": "Complexe coagulant anti-inhibiteur"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3250",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02353903",
      "brand_name": "FEIBA NF",
      "brand_name_fr": "FEIBA NF",
      "descriptor": "1750 TO 3250 UNITS/VIAL & 50 ML DILUENT",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133136003"
    },
    "created_date": "2020-08-11T20:07:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02353903",
    "company_name": "SHIRE PHARMA CANADA ULC",
    "atc_number": "B02BD",
    "atc_description": "VITAMIN K AND OTHER HEMOSTATICS",
    "anticipated_start_date": "2020-08-11T00:00:00-04:00",
    "estimated_end_date": "2020-09-30T00:00:00-04:00",
    "actual_start_date": "2020-08-11T00:00:00-04:00",
    "actual_end_date": "2020-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-10-13T14:22:04-04:00",
    "status": "resolved",
    "en_comments": "Feiba 1000 U is currently available.",
    "fr_comments": "Feiba 1000 U est actuellement disponible.",
    "en_drug_brand_name": "FEIBA NF",
    "en_drug_common_name": "anti-inhibitor coagulant complex",
    "fr_drug_brand_name": "FEIBA",
    "fr_drug_common_name": "complexe coagulant anti-inhibiteur",
    "en_ingredients": "ANTI-INHIBITOR COAGULANT COMPLEX",
    "fr_ingredients": "Complexe coagulant anti-inhibiteur",
    "drug_strength": "3250UNIT",
    "drug_dosage_form": "POWDER FOR SOLUTION\r\nKIT",
    "drug_dosage_form_fr": "Poudre pour solution\r\nTrousse",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "Labelled 2500 U",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122062,
    "drug": {
      "current_status": "MARKETED",
      "id": 16786,
      "drug_code": 77742,
      "updated_date": "2025-05-15T02:31:53-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255932,
          "ingredient": {
            "id": 1474,
            "ingredient_code": 156,
            "en_name": "FAMCICLOVIR",
            "fr_name": "Famciclovir"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02292068",
      "brand_name": "APO-FAMCICLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127885002"
    },
    "created_date": "2020-08-12T13:03:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02292068",
    "company_name": "APOTEX INC",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2021-01-29T00:00:00-05:00",
    "actual_start_date": "2020-08-11T00:00:00-04:00",
    "actual_end_date": "2020-12-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-12-29T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-FAMCICLOVIR",
    "en_drug_common_name": "FAMCICLOVIR",
    "fr_drug_brand_name": "APO-FAMCICLOVIR",
    "fr_drug_common_name": "FAMCICLOVIR",
    "en_ingredients": "FAMCICLOVIR",
    "fr_ingredients": "Famciclovir",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122065,
    "drug": {
      "current_status": "MARKETED",
      "id": 8692,
      "drug_code": 60554,
      "updated_date": "2025-05-15T02:31:05-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253506,
          "ingredient": {
            "id": 2246,
            "ingredient_code": 1855,
            "en_name": "KETOCONAZOLE",
            "fr_name": "Kétoconazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02237235",
      "brand_name": "APO-KETOCONAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116793001"
    },
    "created_date": "2020-08-12T13:13:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237235",
    "company_name": "APOTEX INC",
    "atc_number": "J02AB",
    "atc_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
    "estimated_end_date": "2020-08-28T00:00:00-04:00",
    "actual_start_date": "2020-08-11T00:00:00-04:00",
    "actual_end_date": "2020-08-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-01T19:02:36-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-KETOCONAZOLE",
    "en_drug_common_name": "KETOCONAZOLE",
    "fr_drug_brand_name": "APO-KETOCONAZOLE",
    "fr_drug_common_name": "KETOCONAZOLE",
    "en_ingredients": "KETOCONAZOLE",
    "fr_ingredients": "Kétoconazole",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122068,
    "drug": {
      "current_status": "DORMANT",
      "id": 6332,
      "drug_code": 43222,
      "updated_date": "2025-05-15T06:55:26-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8367206,
          "ingredient": {
            "id": 340,
            "ingredient_code": 1253,
            "en_name": "LISINOPRIL",
            "fr_name": "Lisinopril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02217503",
      "brand_name": "APO-LISINOPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9549",
      "number_of_ais": "1",
      "ai_group_no": "0121550001"
    },
    "created_date": "2020-08-12T13:16:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02217503",
    "company_name": "APOTEX INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2020-10-05T00:00:00-04:00",
    "actual_start_date": "2020-08-11T00:00:00-04:00",
    "actual_end_date": "2020-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-05T12:32:38-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LISINOPRIL TABLET 10 MG",
    "en_drug_common_name": "LISINOPRIL",
    "fr_drug_brand_name": "APO-LISINOPRIL",
    "fr_drug_common_name": "LISINOPRIL",
    "en_ingredients": "LISINOPRIL",
    "fr_ingredients": "Lisinopril",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122071,
    "drug": {
      "current_status": "MARKETED",
      "id": 9488,
      "drug_code": 6297,
      "updated_date": "2025-05-15T02:30:36-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8250873,
          "ingredient": {
            "id": 1210,
            "ingredient_code": 2300,
            "en_name": "LORAZEPAM",
            "fr_name": "Lorazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00655767",
      "brand_name": "APO-LORAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "62760",
      "number_of_ais": "1",
      "ai_group_no": "0110731002"
    },
    "created_date": "2020-08-12T13:34:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00655767",
    "company_name": "APOTEX INC",
    "atc_number": "N05BA",
    "atc_description": "ANXIOLYTICS",
    "estimated_end_date": "2020-10-02T00:00:00-04:00",
    "actual_start_date": "2020-08-11T00:00:00-04:00",
    "actual_end_date": "2020-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-05T12:37:47-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LORAZEPAM TAB 2MG",
    "en_drug_common_name": "LORAZEPAM",
    "fr_drug_brand_name": "APO-LORAZEPAM",
    "fr_drug_common_name": "LORAZEPAM",
    "en_ingredients": "LORAZEPAM",
    "fr_ingredients": "Lorazépam",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122074,
    "drug": {
      "current_status": "MARKETED",
      "id": 312,
      "drug_code": 10830,
      "updated_date": "2025-05-15T02:30:50-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8251402,
          "ingredient": {
            "id": 236,
            "ingredient_code": 11108,
            "en_name": "PRAZOSIN",
            "fr_name": "Prazosine (Chlorhydrate de prazosine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00882836",
      "brand_name": "APO-PRAZO",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70923",
      "number_of_ais": "1",
      "ai_group_no": "0111527003"
    },
    "created_date": "2020-08-12T13:41:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00882836",
    "company_name": "APOTEX INC",
    "atc_number": "C02CA",
    "atc_description": "ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",
    "estimated_end_date": "2020-10-28T00:00:00-04:00",
    "actual_start_date": "2020-08-11T00:00:00-04:00",
    "actual_end_date": "2020-10-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-19T12:49:31-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PRAZO TAB 5MG",
    "en_drug_common_name": "PRAZO",
    "fr_drug_brand_name": "APO-PRAZO",
    "fr_drug_common_name": "PRAZO",
    "en_ingredients": "PRAZOSIN",
    "fr_ingredients": "PRAZOSIN",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122077,
    "drug": {
      "current_status": "DORMANT",
      "id": 18668,
      "drug_code": 79944,
      "updated_date": "2025-05-15T06:55:37-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368175,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02313928",
      "brand_name": "APO-QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858002"
    },
    "created_date": "2020-08-12T13:48:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02313928",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2020-09-01T00:00:00-04:00",
    "actual_start_date": "2020-08-11T00:00:00-04:00",
    "actual_end_date": "2020-09-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-04T17:47:27-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-QUETIAPINE",
    "en_drug_common_name": "QUETIAPINE",
    "fr_drug_brand_name": "APO-QUETIAPINE",
    "fr_drug_common_name": "QUETIAPINE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122080,
    "drug": {
      "current_status": "DORMANT",
      "id": 18666,
      "drug_code": 79943,
      "updated_date": "2025-05-15T06:55:37-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368174,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02313901",
      "brand_name": "APO-QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858001"
    },
    "created_date": "2020-08-12T15:26:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02313901",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2020-09-03T00:00:00-04:00",
    "actual_start_date": "2020-08-11T00:00:00-04:00",
    "actual_end_date": "2020-09-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-04T17:48:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-QUETIAPINE",
    "en_drug_common_name": "QUETIAPINE",
    "fr_drug_brand_name": "APO-QUETIAPINE",
    "fr_drug_common_name": "QUETIAPINE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122085,
    "drug": {
      "current_status": "MARKETED",
      "id": 3934,
      "drug_code": 19587,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252512,
          "ingredient": {
            "id": 1414,
            "ingredient_code": 5325,
            "en_name": "LEVOTHYROXINE SODIUM",
            "fr_name": "Lévothyroxine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02172070",
      "brand_name": "SYNTHROID",
      "brand_name_fr": "",
      "descriptor": "TAB 50MCG",
      "pediatric_flag": false,
      "accession_number": "81884",
      "number_of_ais": "1",
      "ai_group_no": "0107794025"
    },
    "created_date": "2020-08-13T12:09:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02172070",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "H03AA",
    "atc_description": "THYROID PREPARATIONS",
    "estimated_end_date": "2020-09-08T00:00:00-04:00",
    "actual_start_date": "2020-07-31T00:00:00-04:00",
    "actual_end_date": "2020-09-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-02T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SYNTHROID",
    "en_drug_common_name": "LEVOTHYROXINE",
    "fr_drug_brand_name": "SYNTHROID",
    "fr_drug_common_name": "LEVOTHYROXINE",
    "en_ingredients": "LEVOTHYROXINE SODIUM",
    "fr_ingredients": "Lévothyroxine sodique",
    "drug_strength": "50MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122088,
    "drug": {
      "current_status": "MARKETED",
      "id": 1522,
      "drug_code": 13302,
      "updated_date": "2025-05-15T02:30:53-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251750,
          "ingredient": {
            "id": 572,
            "ingredient_code": 649,
            "en_name": "LIPASE",
            "fr_name": "Lipase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251749,
          "ingredient": {
            "id": 570,
            "ingredient_code": 648,
            "en_name": "PROTEASE",
            "fr_name": "Protéase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1600",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251748,
          "ingredient": {
            "id": 568,
            "ingredient_code": 253,
            "en_name": "AMYLASE",
            "fr_name": "Amylase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25500",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01985205",
      "brand_name": "CREON MINIMICROSPHERES 25",
      "brand_name_fr": "CREON MINIMICROSPHERES 25",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74650",
      "number_of_ais": "3",
      "ai_group_no": "0302964041"
    },
    "created_date": "2020-08-13T12:12:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01985205",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "A09AA",
    "atc_description": "DIGESTIVES, INCL ENZYMES",
    "estimated_end_date": "2020-08-18T00:00:00-04:00",
    "actual_start_date": "2020-08-10T00:00:00-04:00",
    "actual_end_date": "2020-08-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-08-18T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CREON MINIMICROSPHERES 25",
    "en_drug_common_name": "CREON MINIMICROSPHERES 25",
    "fr_drug_brand_name": "CREON MINIMICROSPHERES 25",
    "fr_drug_common_name": "CREON MINIMICROSPHERES 25",
    "en_ingredients": "LIPASE\r\nAMYLASE\r\nPROTEASE",
    "fr_ingredients": "Lipase\r\nAmylase\r\nProtéase",
    "drug_strength": "25000UNIT\r\n25500UNIT\r\n1600UNIT",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "25",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122091,
    "drug": {
      "current_status": "MARKETED",
      "id": 6304,
      "drug_code": 43175,
      "updated_date": "2025-05-15T02:31:02-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8253034,
          "ingredient": {
            "id": 886,
            "ingredient_code": 7558,
            "en_name": "CLOBETASOL PROPIONATE",
            "fr_name": "Propionate de clobétasol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02216213",
      "brand_name": "MYLAN-CLOBETASOL SCALP APPLICATION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9488",
      "number_of_ais": "1",
      "ai_group_no": "0110995001"
    },
    "created_date": "2020-08-13T12:14:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02216213",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "D07AD",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "anticipated_start_date": "2020-08-14T00:00:00-04:00",
    "estimated_end_date": "2020-11-10T00:00:00-05:00",
    "actual_start_date": "2020-08-10T00:00:00-04:00",
    "actual_end_date": "2020-11-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-10T12:50:16-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-CLOBETASOL SCALP APPLICATION",
    "en_drug_common_name": "CLOBETASOL SCALP APPLICATION",
    "fr_drug_brand_name": "MYLAN-CLOBETASOL SCALP APPLICATION",
    "fr_drug_common_name": "CLOBETASOL SCALP APPLICATION",
    "en_ingredients": "CLOBETASOL PROPIONATE",
    "fr_ingredients": "Propionate de clobétasol",
    "drug_strength": "0.05%",
    "drug_dosage_form": "LOTION",
    "drug_dosage_form_fr": "Lotion",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "1",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122102,
    "drug": {
      "current_status": "MARKETED",
      "id": 6264,
      "drug_code": 4309,
      "updated_date": "2025-05-15T02:30:31-04:00",
      "company": {
        "id": 510,
        "created_date": "2017-03-09T13:22:50-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16647,
        "mfr_code": "",
        "name": "SEARCHLIGHT PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1600 RUE NOTRE DAME OUEST, SUITE 312",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3J 1M1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250626,
          "ingredient": {
            "id": 2136,
            "ingredient_code": 11355,
            "en_name": "PHENELZINE",
            "fr_name": "Phénelzine (Sulfate de phénelzine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "00476552",
      "brand_name": "NARDIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "57340",
      "number_of_ais": "1",
      "ai_group_no": "0106952001"
    },
    "created_date": "2020-08-13T14:43:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00476552",
    "company_name": "ERFA CANADA 2012 INC",
    "atc_number": "N06AF",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2020-11-01T00:00:00-04:00",
    "estimated_end_date": "2021-06-16T00:00:00-04:00",
    "actual_start_date": "2020-10-06T00:00:00-04:00",
    "actual_end_date": "2021-06-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2021-06-17T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "NARDIL",
    "en_drug_common_name": "NARDIL",
    "fr_drug_brand_name": "NARDIL",
    "fr_drug_common_name": "NARDIL",
    "en_ingredients": "PHENELZINE",
    "fr_ingredients": "PHENELZINE",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60 TABS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122119,
    "drug": {
      "current_status": "MARKETED",
      "id": 23332,
      "drug_code": 85917,
      "updated_date": "2025-05-15T02:33:03-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258412,
          "ingredient": {
            "id": 3742,
            "ingredient_code": 20982,
            "en_name": "COLESEVELAM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de Colésévélam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "625",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02373955",
      "brand_name": "LODALIS",
      "brand_name_fr": "",
      "descriptor": "FILM-COATED TABLETS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0153000001"
    },
    "created_date": "2020-08-13T15:02:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02373955",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "C10AC",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "actual_start_date": "2020-07-28T00:00:00-04:00",
    "actual_end_date": "2020-09-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-09-10T14:37:12-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LODALIS",
    "en_drug_common_name": "LODALIS",
    "fr_drug_brand_name": "LODALIS",
    "fr_drug_common_name": "LODALIS",
    "en_ingredients": "COLESEVELAM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de Colésévélam",
    "drug_strength": "625MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "180's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122122,
    "drug": {
      "current_status": "MARKETED",
      "id": 3456,
      "drug_code": 18744,
      "updated_date": "2025-12-03T00:30:33-05:00",
      "company": {
        "id": 412,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5661,
        "mfr_code": "BSH95",
        "name": "BAUSCH & LOMB INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1400 N GOODMAN STREET",
        "province": "NEW YORK",
        "country": "UNITED STATES",
        "city": "ROCHESTER",
        "postal_code": "14609",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252366,
          "ingredient": {
            "id": 1470,
            "ingredient_code": 6598,
            "en_name": "PILOCARPINE NITRATE",
            "fr_name": "Nitrate de pilocarpine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02148463",
      "brand_name": "MINIMS PILOCARPINE NITRATE",
      "brand_name_fr": "MINIMS NITRATE DE PILOCARPINE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81018",
      "number_of_ais": "1",
      "ai_group_no": "0107359002"
    },
    "created_date": "2020-08-13T15:04:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02148463",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "S01EB",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "actual_start_date": "2020-08-03T00:00:00-04:00",
    "actual_end_date": "2020-09-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2020-09-23T20:54:09-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MINIMS PILOCARPINE NITRATE 2%",
    "en_drug_common_name": "MINIMS PILOCARPINE NITRATE 2%",
    "fr_drug_brand_name": "MINIMS PILOCARPINE NITRATE 2%",
    "fr_drug_common_name": "MINIMS PILOCARPINE NITRATE 2%",
    "en_ingredients": "PILOCARPINE NITRATE",
    "fr_ingredients": "Nitrate de pilocarpine",
    "drug_strength": "2%",
    "drug_dosage_form": "DROPS",
    "drug_dosage_form_fr": "Gouttes",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "n/a",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122194,
    "drug": {
      "current_status": "MARKETED",
      "id": 15838,
      "drug_code": 76587,
      "updated_date": "2025-05-15T02:31:45-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255671,
          "ingredient": {
            "id": 2896,
            "ingredient_code": 9483,
            "en_name": "BETAHISTINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bétahistine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02280191",
      "brand_name": "TEVA-BETAHISTINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103555003"
    },
    "created_date": "2020-08-13T19:12:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02280191",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N07CA",
    "atc_description": "ANTIVERTIGO PREPARATIONS",
    "estimated_end_date": "2020-10-31T00:00:00-04:00",
    "actual_start_date": "2020-08-12T00:00:00-04:00",
    "actual_end_date": "2020-10-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-08T18:50:55-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-BETAHISTINE",
    "en_drug_common_name": "TEVA-BETAHISTINE 16MG TABLETS",
    "fr_drug_brand_name": "TEVA-BETAHISTINE",
    "fr_drug_common_name": "TEVA-BETAHISTINE 16MG TABLETS",
    "en_ingredients": "BETAHISTINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bêta-histine",
    "drug_strength": "16MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122198,
    "drug": {
      "current_status": "MARKETED",
      "id": 15840,
      "drug_code": 76588,
      "updated_date": "2025-05-15T02:31:45-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255672,
          "ingredient": {
            "id": 2896,
            "ingredient_code": 9483,
            "en_name": "BETAHISTINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bétahistine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "24",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02280205",
      "brand_name": "TEVA-BETAHISTINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103555004"
    },
    "created_date": "2020-08-13T19:14:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02280205",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N07CA",
    "atc_description": "ANTIVERTIGO PREPARATIONS",
    "estimated_end_date": "2020-10-31T00:00:00-04:00",
    "actual_start_date": "2020-08-12T00:00:00-04:00",
    "actual_end_date": "2020-10-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-08T18:51:14-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-BETAHISTINE",
    "en_drug_common_name": "TEVA-BETAHISTINE 24MG TABLETS",
    "fr_drug_brand_name": "TEVA-BETAHISTINE",
    "fr_drug_common_name": "TEVA-BETAHISTINE 24MG TABLETS",
    "en_ingredients": "BETAHISTINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bêta-histine",
    "drug_strength": "24MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122201,
    "drug": {
      "current_status": "MARKETED",
      "id": 66087,
      "drug_code": 95113,
      "updated_date": "2025-05-15T02:35:51-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262461,
          "ingredient": {
            "id": 3624,
            "ingredient_code": 13238,
            "en_name": "EVEROLIMUS",
            "fr_name": "Évérolimus"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02463229",
      "brand_name": "TEVA-EVEROLIMUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152682003"
    },
    "created_date": "2020-08-13T19:15:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02463229",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L01XE",
    "atc_description": "OTHER ANTINEOPLASTIC AGENTS",
    "estimated_end_date": "2020-09-30T00:00:00-04:00",
    "actual_start_date": "2020-08-12T00:00:00-04:00",
    "actual_end_date": "2020-09-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-03T18:02:46-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-EVEROLIMUS",
    "en_drug_common_name": "TEVA-EVEROLIMUS 2.5MG TABS",
    "fr_drug_brand_name": "TEVA-EVEROLIMUS",
    "fr_drug_common_name": "TEVA-EVEROLIMUS 2.5MG TABS",
    "en_ingredients": "EVEROLIMUS",
    "fr_ingredients": "Évérolimus",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122204,
    "drug": {
      "current_status": "MARKETED",
      "id": 18386,
      "drug_code": 79654,
      "updated_date": "2025-05-15T02:32:10-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256442,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02310929",
      "brand_name": "TEVA-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055004"
    },
    "created_date": "2020-08-13T19:15:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02310929",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2020-10-31T00:00:00-04:00",
    "actual_start_date": "2020-08-12T00:00:00-04:00",
    "actual_end_date": "2020-10-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-08T18:51:38-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ATORVASTATIN",
    "en_drug_common_name": "TEVA-ATORVASTATIN 80MG FC TABLETS",
    "fr_drug_brand_name": "TEVA-ATORVASTATIN",
    "fr_drug_common_name": "TEVA-ATORVASTATIN 80MG FC TABLETS",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "ATORVASTATIN",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122208,
    "drug": {
      "current_status": "MARKETED",
      "id": 17404,
      "drug_code": 78462,
      "updated_date": "2025-12-03T00:31:15-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256136,
          "ingredient": {
            "id": 1170,
            "ingredient_code": 11388,
            "en_name": "FLUVASTATIN",
            "fr_name": "Fluvastatine (Fluvastatine sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02299232",
      "brand_name": "TEVA-FLUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125247001"
    },
    "created_date": "2020-08-13T19:17:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02299232",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2021-03-31T00:00:00-04:00",
    "actual_start_date": "2020-08-12T00:00:00-04:00",
    "actual_end_date": "2021-03-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-03-25T15:25:23-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-FLUVASTATIN",
    "en_drug_common_name": "TEVA-FLUVASTATIN 40MG CAPSULES",
    "fr_drug_brand_name": "TEVA-FLUVASTATIN",
    "fr_drug_common_name": "TEVA-FLUVASTATIN 40MG CAPSULES",
    "en_ingredients": "FLUVASTATIN",
    "fr_ingredients": "FLUVASTATIN",
    "drug_strength": "40MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122211,
    "drug": {
      "current_status": "MARKETED",
      "id": 55822,
      "drug_code": 95215,
      "updated_date": "2025-05-15T02:35:51-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262504,
          "ingredient": {
            "id": 1286,
            "ingredient_code": 232,
            "en_name": "PERINDOPRIL ERBUMINE",
            "fr_name": "Périndopril erbumine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8262503,
          "ingredient": {
            "id": 1366,
            "ingredient_code": 1960,
            "en_name": "INDAPAMIDE",
            "fr_name": "Indapamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02464039",
      "brand_name": "TEVA-PERINDOPRIL/INDAPAMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0248401003"
    },
    "created_date": "2020-08-13T19:18:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02464039",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09BA",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "estimated_end_date": "2020-10-31T00:00:00-04:00",
    "actual_start_date": "2020-08-12T00:00:00-04:00",
    "actual_end_date": "2020-10-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-22T17:08:21-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PERINDOPRIL/INDAPAMIDE",
    "en_drug_common_name": "TEVA-PERIN/INDA 8MG/2.5MG TABS",
    "fr_drug_brand_name": "TEVA-PERIN/INDA",
    "fr_drug_common_name": "TEVA-PERIN/INDA 8MG/2.5MG TABS",
    "en_ingredients": "PERINDOPRIL ERBUMINE\r\nINDAPAMIDE",
    "fr_ingredients": "Périndopril erbumine\r\nIndapamide",
    "drug_strength": "8MG\r\n2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122214,
    "drug": {
      "current_status": "MARKETED",
      "id": 17050,
      "drug_code": 78072,
      "updated_date": "2025-05-15T02:31:56-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256015,
          "ingredient": {
            "id": 1598,
            "ingredient_code": 1250,
            "en_name": "OMEPRAZOLE",
            "fr_name": "Oméprazole (Oméprazole magnésium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02295415",
      "brand_name": "TEVA-OMEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121643001"
    },
    "created_date": "2020-08-13T19:19:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02295415",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2020-11-30T00:00:00-05:00",
    "actual_start_date": "2020-08-12T00:00:00-04:00",
    "actual_end_date": "2020-12-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-12-03T20:09:32-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-OMEPRAZOLE",
    "en_drug_common_name": "TEVA-OMEPRAZOLE 20MG TABLETS",
    "fr_drug_brand_name": "TEVA-OMEPRAZOLE",
    "fr_drug_common_name": "TEVA-OMEPRAZOLE 20MG TABLETS",
    "en_ingredients": "OMEPRAZOLE",
    "fr_ingredients": "Oméprazole",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122217,
    "drug": {
      "current_status": "MARKETED",
      "id": 8276,
      "drug_code": 5646,
      "updated_date": "2025-05-15T02:30:34-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250793,
          "ingredient": {
            "id": 1010,
            "ingredient_code": 7408,
            "en_name": "SPIRONOLACTONE",
            "fr_name": "Spironolactone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00613215",
      "brand_name": "TEVA-SPIRONOLACTONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "61191",
      "number_of_ais": "1",
      "ai_group_no": "0106462001"
    },
    "created_date": "2020-08-13T19:20:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00613215",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C03DA",
    "atc_description": "POTASSIUM-SPARING AGENTS",
    "estimated_end_date": "2020-11-30T00:00:00-05:00",
    "actual_start_date": "2020-08-12T00:00:00-04:00",
    "actual_end_date": "2020-11-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-07T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-SPIRONOLACTONE",
    "en_drug_common_name": "TEVA-SPIRONOLACTONE 25MG TABLETS",
    "fr_drug_brand_name": "TEVA-SPIRONOLACTONE",
    "fr_drug_common_name": "TEVA-SPIRONOLACTONE 25MG TABLETS",
    "en_ingredients": "SPIRONOLACTONE",
    "fr_ingredients": "Spironolactone",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100,500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122222,
    "drug": {
      "current_status": "DORMANT",
      "id": 28594,
      "drug_code": 90700,
      "updated_date": "2025-12-03T02:32:36-05:00",
      "company": {
        "id": 16976,
        "created_date": "2020-10-02T23:51:29-04:00",
        "updated_date": "2025-12-03T00:30:15-05:00",
        "company_code": 17602,
        "mfr_code": "",
        "name": "HIKMA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "55 STANDISH COURT, SUITE 1050",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 0G3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369087,
          "ingredient": {
            "id": 2134,
            "ingredient_code": 11118,
            "en_name": "CEFUROXIME",
            "fr_name": "Céfuroxime (Céfuroxime sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02422301",
      "brand_name": "CEFUROXIME FOR INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122448008"
    },
    "created_date": "2020-08-13T19:23:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02422301",
    "company_name": "STERIMAX INC",
    "atc_number": "J01DC",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "actual_start_date": "2020-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-08-13T19:28:50-04:00",
    "status": "active_confirmed",
    "en_comments": "BUSINESS REASONS",
    "fr_comments": "RAISONS COMMERCIALES",
    "en_drug_brand_name": "CEFUROXIME FOR INJECTION, USP",
    "en_drug_common_name": "CEFUROXIME FOR INJECTION, USP",
    "fr_drug_brand_name": "CEFUROXIME POUR INJECTION USP",
    "fr_drug_common_name": "CEFUROXIME POUR INJECTION USP",
    "en_ingredients": "CEFUROXIME",
    "fr_ingredients": "CEFUROXIME",
    "drug_strength": "1.5G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "25 VIALS",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122225,
    "drug": {
      "current_status": "DORMANT",
      "id": 28596,
      "drug_code": 90701,
      "updated_date": "2025-12-03T02:32:36-05:00",
      "company": {
        "id": 16976,
        "created_date": "2020-10-02T23:51:29-04:00",
        "updated_date": "2025-12-03T00:30:15-05:00",
        "company_code": 17602,
        "mfr_code": "",
        "name": "HIKMA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "55 STANDISH COURT, SUITE 1050",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 0G3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369088,
          "ingredient": {
            "id": 2134,
            "ingredient_code": 11118,
            "en_name": "CEFUROXIME",
            "fr_name": "Céfuroxime (Céfuroxime sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "7.5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02422328",
      "brand_name": "CEFUROXIME FOR INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122448009"
    },
    "created_date": "2020-08-13T19:29:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02422328",
    "company_name": "STERIMAX INC",
    "atc_number": "J01DC",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "actual_start_date": "2020-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-08-13T19:30:31-04:00",
    "status": "active_confirmed",
    "en_comments": "BUSINESS REASONS.",
    "fr_comments": "RAISONS COMMERCIALES",
    "en_drug_brand_name": "CEFUROXIME FOR INJECTION, USP",
    "en_drug_common_name": "CEFUROXIME FOR INJECTION, USP",
    "fr_drug_brand_name": "CEFUROXIME POUR INJECTION USP",
    "fr_drug_common_name": "CEFUROXIME POUR INJECTION USP",
    "en_ingredients": "CEFUROXIME",
    "fr_ingredients": "CEFUROXIME",
    "drug_strength": "7.5G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 VIALS",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122228,
    "drug": {
      "current_status": "DORMANT",
      "id": 28592,
      "drug_code": 90699,
      "updated_date": "2025-12-03T02:32:36-05:00",
      "company": {
        "id": 16976,
        "created_date": "2020-10-02T23:51:29-04:00",
        "updated_date": "2025-12-03T00:30:15-05:00",
        "company_code": 17602,
        "mfr_code": "",
        "name": "HIKMA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "55 STANDISH COURT, SUITE 1050",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 0G3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369086,
          "ingredient": {
            "id": 2134,
            "ingredient_code": 11118,
            "en_name": "CEFUROXIME",
            "fr_name": "Céfuroxime (Céfuroxime sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "750",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02422298",
      "brand_name": "CEFUROXIME FOR INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122448004"
    },
    "created_date": "2020-08-13T19:31:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02422298",
    "company_name": "STERIMAX INC",
    "atc_number": "J01DC",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "anticipated_start_date": "2020-10-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-10-31T05:00:02-04:00",
    "status": "active_confirmed",
    "en_comments": "BUSINESS REASONS.",
    "fr_comments": "RAISONS COMMERCIALES.",
    "en_drug_brand_name": "CEFUROXIME FOR INJECTION, USP",
    "en_drug_common_name": "CEFUROXIME FOR INJECTION, USP",
    "fr_drug_brand_name": "CEFUROXIME POUR INJECTION USP",
    "fr_drug_common_name": "CEFUROXIME POUR INJECTION USP",
    "en_ingredients": "CEFUROXIME",
    "fr_ingredients": "CEFUROXIME",
    "drug_strength": "750MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "25 VIALS",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122239,
    "drug": {
      "current_status": "MARKETED",
      "id": 6250,
      "drug_code": 43078,
      "updated_date": "2025-05-15T02:31:02-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253028,
          "ingredient": {
            "id": 2132,
            "ingredient_code": 11323,
            "en_name": "SUMATRIPTAN",
            "fr_name": "Sumatriptan (Succinate de sumatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02212188",
      "brand_name": "IMITREX",
      "brand_name_fr": "",
      "descriptor": "AUTO-INJECTOR",
      "pediatric_flag": false,
      "accession_number": "P9370",
      "number_of_ais": "1",
      "ai_group_no": "0123238006"
    },
    "created_date": "2020-08-14T13:41:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02212188",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2020-09-09T00:00:00-04:00",
    "actual_start_date": "2020-08-10T00:00:00-04:00",
    "actual_end_date": "2020-09-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-09-10T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "IMITREX",
    "en_drug_common_name": "sumatriptan succinate injection",
    "fr_drug_brand_name": "IMITREX",
    "fr_drug_common_name": "solution injectable de succinate de sumatriptan",
    "en_ingredients": "SUMATRIPTAN",
    "fr_ingredients": "Sumatriptan (Succinate de sumatriptan)",
    "drug_strength": "6MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "5x0.5mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122250,
    "drug": {
      "current_status": "MARKETED",
      "id": 6724,
      "drug_code": 44185,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 458,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 12573,
        "mfr_code": "",
        "name": "GE HEALTHCARE CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1919 MINNESOTA COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C9",
        "post_office_box": "",
        "contact_information": "800-387-7146   \r\n\r\ncanadainfo@gehealthcare.com"
      },
      "drug_ingredients": [
        {
          "id": 8253159,
          "ingredient": {
            "id": 2234,
            "ingredient_code": 8092,
            "en_name": "IOHEXOL",
            "fr_name": "Iohexol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "518",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02172739",
      "brand_name": "OMNIPAQUE 240",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "T9819",
      "number_of_ais": "1",
      "ai_group_no": "0116846003"
    },
    "created_date": "2020-08-14T15:53:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02172739",
    "company_name": "GE HEALTHCARE CANADA INC",
    "atc_number": "V08AB",
    "atc_description": "X-RAY CONTRAST MEDIA, IODINATED",
    "anticipated_start_date": "2020-09-15T00:00:00-04:00",
    "estimated_end_date": "2020-09-25T00:00:00-04:00",
    "actual_start_date": "2020-09-16T00:00:00-04:00",
    "actual_end_date": "2020-09-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-09-26T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "OMNIPAQUE 240",
    "en_drug_common_name": "IOHEXOL INJECTION USP",
    "fr_drug_brand_name": "OMNIPAQUE 240",
    "fr_drug_common_name": "iohexol injectable USP",
    "en_ingredients": "IOHEXOL",
    "fr_ingredients": "Iohexol",
    "drug_strength": "518MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBARACHNOIDAL\r\nINTRAVASCULAR\r\nSUBARACHNOIDAL\r\nINTRAVASCULAR",
    "drug_route_fr": "Sous-arachnoÏdienne\r\nIntravasculaire\r\nSous-arachnoÏdienne\r\nIntravasculaire",
    "drug_package_quantity": "20 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122257,
    "drug": {
      "current_status": "MARKETED",
      "id": 6724,
      "drug_code": 44185,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 458,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 12573,
        "mfr_code": "",
        "name": "GE HEALTHCARE CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1919 MINNESOTA COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C9",
        "post_office_box": "",
        "contact_information": "800-387-7146   \r\n\r\ncanadainfo@gehealthcare.com"
      },
      "drug_ingredients": [
        {
          "id": 8253159,
          "ingredient": {
            "id": 2234,
            "ingredient_code": 8092,
            "en_name": "IOHEXOL",
            "fr_name": "Iohexol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "518",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02172739",
      "brand_name": "OMNIPAQUE 240",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "T9819",
      "number_of_ais": "1",
      "ai_group_no": "0116846003"
    },
    "created_date": "2020-08-14T15:57:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02172739",
    "company_name": "GE HEALTHCARE CANADA INC",
    "atc_number": "V08AB",
    "atc_description": "X-RAY CONTRAST MEDIA, IODINATED",
    "anticipated_start_date": "2020-09-08T00:00:00-04:00",
    "estimated_end_date": "2020-09-14T00:00:00-04:00",
    "actual_start_date": "2020-09-08T00:00:00-04:00",
    "actual_end_date": "2020-09-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-09-15T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "OMNIPAQUE 240",
    "en_drug_common_name": "IOHEXOL INJECTION USP",
    "fr_drug_brand_name": "OMNIPAQUE 240",
    "fr_drug_common_name": "iohexol injectable USP",
    "en_ingredients": "IOHEXOL",
    "fr_ingredients": "Iohexol",
    "drug_strength": "518MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBARACHNOIDAL\r\nINTRAVASCULAR\r\nSUBARACHNOIDAL\r\nINTRAVASCULAR",
    "drug_route_fr": "Sous-arachnoÏdienne\r\nIntravasculaire\r\nSous-arachnoÏdienne\r\nIntravasculaire",
    "drug_package_quantity": "50 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122276,
    "drug": {
      "current_status": "MARKETED",
      "id": 12996,
      "drug_code": 72247,
      "updated_date": "2025-05-15T02:31:28-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254747,
          "ingredient": {
            "id": 1940,
            "ingredient_code": 10140,
            "en_name": "HYDROXYUREA",
            "fr_name": "Hydroxyurée"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247937",
      "brand_name": "APO-HYDROXYUREA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113432001"
    },
    "created_date": "2020-08-14T18:27:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247937",
    "company_name": "APOTEX INC",
    "atc_number": "L01XX",
    "atc_description": "OTHER ANTINEOPLASTIC AGENTS",
    "estimated_end_date": "2020-11-16T00:00:00-05:00",
    "actual_start_date": "2020-08-10T00:00:00-04:00",
    "actual_end_date": "2020-11-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-11-18T19:51:58-05:00",
    "status": "resolved",
    "en_comments": "Allocating the limited inventory",
    "fr_comments": "Allocating the limited inventory",
    "en_drug_brand_name": "APO-HYDROXYUREA",
    "en_drug_common_name": "HYDROXYUREA",
    "fr_drug_brand_name": "APO-HYDROXYUREA",
    "fr_drug_common_name": "HYDROXYUREA",
    "en_ingredients": "HYDROXYUREA",
    "fr_ingredients": "Hydroxyurée",
    "drug_strength": "500MG",
    "drug_dosage_form": "CAPSULE\r\nCAPSULE",
    "drug_dosage_form_fr": "Capsule\r\nCapsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122292,
    "drug": {
      "current_status": "MARKETED",
      "id": 25540,
      "drug_code": 87964,
      "updated_date": "2025-05-15T02:33:40-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8259225,
          "ingredient": {
            "id": 340,
            "ingredient_code": 1253,
            "en_name": "LISINOPRIL",
            "fr_name": "Lisinopril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02394480",
      "brand_name": "AURO-LISINOPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121550001"
    },
    "created_date": "2020-08-14T21:57:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02394480",
    "company_name": "AURO PHARMA INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2020-11-30T00:00:00-05:00",
    "actual_start_date": "2020-08-13T00:00:00-04:00",
    "actual_end_date": "2020-11-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-12-04T21:58:26-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-LISINOPRIL",
    "en_drug_common_name": "Lisinopril",
    "fr_drug_brand_name": "AURO-LISINOPRIL",
    "fr_drug_common_name": "Lisinopril",
    "en_ingredients": "LISINOPRIL",
    "fr_ingredients": "Lisinopril",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122295,
    "drug": {
      "current_status": "MARKETED",
      "id": 25542,
      "drug_code": 87965,
      "updated_date": "2025-05-15T02:33:40-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8259226,
          "ingredient": {
            "id": 340,
            "ingredient_code": 1253,
            "en_name": "LISINOPRIL",
            "fr_name": "Lisinopril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02394499",
      "brand_name": "AURO-LISINOPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121550002"
    },
    "created_date": "2020-08-14T22:00:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02394499",
    "company_name": "AURO PHARMA INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2020-11-30T00:00:00-05:00",
    "actual_start_date": "2020-08-13T00:00:00-04:00",
    "actual_end_date": "2020-11-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-12-03T17:10:14-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-LISINOPRIL",
    "en_drug_common_name": "Lisinopril",
    "fr_drug_brand_name": "AURO-LISINOPRIL",
    "fr_drug_common_name": "Lisinopril",
    "en_ingredients": "LISINOPRIL",
    "fr_ingredients": "Lisinopril",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122300,
    "drug": {
      "current_status": "MARKETED",
      "id": 24722,
      "drug_code": 87297,
      "updated_date": "2025-05-15T02:33:31-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8258920,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02387387",
      "brand_name": "AURO-RAMIPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122858001"
    },
    "created_date": "2020-08-14T22:04:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02387387",
    "company_name": "AURO PHARMA INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2021-03-01T00:00:00-05:00",
    "actual_start_date": "2020-08-13T00:00:00-04:00",
    "actual_end_date": "2021-02-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-02-18T20:25:36-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-RAMIPRIL",
    "en_drug_common_name": "Ramipril",
    "fr_drug_brand_name": "AURO-RAMIPRIL",
    "fr_drug_common_name": "Ramipril",
    "en_ingredients": "RAMIPRIL",
    "fr_ingredients": "Ramipril",
    "drug_strength": "1.25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100s",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122317,
    "drug": {
      "current_status": "MARKETED",
      "id": 9514,
      "drug_code": 63077,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 468,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 5362,
        "mfr_code": "VLH07",
        "name": "LUNDBECK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2600 ALFRED-NOBEL, SUITE 400",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-LAURENT",
        "postal_code": "H4S 0A9",
        "post_office_box": "",
        "contact_information": "514-844-8515  / Canada@Lundbeck.com"
      },
      "drug_ingredients": [
        {
          "id": 8253700,
          "ingredient": {
            "id": 2658,
            "ingredient_code": 11847,
            "en_name": "CITALOPRAM",
            "fr_name": "Citalopram (Bromhydrate de citalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02239607",
      "brand_name": "CELEXA 20 MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136243001"
    },
    "created_date": "2020-08-17T02:28:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02239607",
    "company_name": "LUNDBECK CANADA INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "actual_start_date": "2020-08-12T00:00:00-04:00",
    "actual_end_date": "2020-08-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-08-28T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Strike at Port of Montreal. Two presentations of Celexa 20mg (100 tablet bottle and 250 tablet bottle) remain available and have not been impacted by the labour disruption.",
    "fr_comments": "Grève au Port de Montréal. Deux présentations de Celexa 20mg (flacon de 100 comprimés et flacon de 250 comprimés) sont toujours disponibles et n’ont pas été affectées par l’interruption de travail.",
    "en_drug_brand_name": "CELEXA 20 MG",
    "en_drug_common_name": "citalopram",
    "fr_drug_brand_name": "CELEXA - 20MG",
    "fr_drug_common_name": "citalopram",
    "en_ingredients": "CITALOPRAM",
    "fr_ingredients": "CITALOPRAM",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Blister pack of 30 tablets / Plaquette alvéolée de 30 comprimés",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122375,
    "drug": {
      "current_status": "MARKETED",
      "id": 20710,
      "drug_code": 82495,
      "updated_date": "2025-05-15T02:32:33-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257328,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "526",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8257327,
          "ingredient": {
            "id": 678,
            "ingredient_code": 10292,
            "en_name": "SODIUM ACETATE",
            "fr_name": "Acétate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "368",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8257326,
          "ingredient": {
            "id": 44,
            "ingredient_code": 53,
            "en_name": "POTASSIUM CHLORIDE",
            "fr_name": "Chlorure de potassium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "37",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8257325,
          "ingredient": {
            "id": 12,
            "ingredient_code": 49,
            "en_name": "MAGNESIUM CHLORIDE",
            "fr_name": "Chlorure de magnésium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8257324,
          "ingredient": {
            "id": 680,
            "ingredient_code": 6787,
            "en_name": "SODIUM GLUCONATE",
            "fr_name": "Gluconate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "502",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02339358",
      "brand_name": "PLASMA-LYTE A INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "5",
      "ai_group_no": "0500064002"
    },
    "created_date": "2020-08-17T14:10:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02339358",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05BB",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2020-08-17T00:00:00-04:00",
    "estimated_end_date": "2020-08-31T00:00:00-04:00",
    "actual_start_date": "2020-08-17T00:00:00-04:00",
    "actual_end_date": "2020-08-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-09-01T05:00:12-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PLASMA-LYTE A INJECTION",
    "en_drug_common_name": "PLASMA-LYTE A INJECTION",
    "fr_drug_brand_name": "PLASMA-LYTE A INJECTION",
    "fr_drug_common_name": "PLASMA-LYTE A INJECTION",
    "en_ingredients": "SODIUM CHLORIDE\r\nSODIUM ACETATE\r\nSODIUM GLUCONATE\r\nPOTASSIUM CHLORIDE\r\nMAGNESIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium\r\nAcétate de sodium\r\nGluconate de sodium\r\nChlorure de potassium\r\nChlorure de magnésium",
    "drug_strength": "526MG\r\n368MG\r\n502MG\r\n37MG\r\n30MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1000mL (JB2544)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122377,
    "drug": {
      "current_status": "MARKETED",
      "id": 20710,
      "drug_code": 82495,
      "updated_date": "2025-05-15T02:32:33-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257328,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "526",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8257327,
          "ingredient": {
            "id": 678,
            "ingredient_code": 10292,
            "en_name": "SODIUM ACETATE",
            "fr_name": "Acétate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "368",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8257326,
          "ingredient": {
            "id": 44,
            "ingredient_code": 53,
            "en_name": "POTASSIUM CHLORIDE",
            "fr_name": "Chlorure de potassium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "37",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8257325,
          "ingredient": {
            "id": 12,
            "ingredient_code": 49,
            "en_name": "MAGNESIUM CHLORIDE",
            "fr_name": "Chlorure de magnésium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8257324,
          "ingredient": {
            "id": 680,
            "ingredient_code": 6787,
            "en_name": "SODIUM GLUCONATE",
            "fr_name": "Gluconate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "502",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02339358",
      "brand_name": "PLASMA-LYTE A INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "5",
      "ai_group_no": "0500064002"
    },
    "created_date": "2020-08-17T14:10:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02339358",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05BB",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2020-08-17T00:00:00-04:00",
    "estimated_end_date": "2020-08-31T00:00:00-04:00",
    "actual_start_date": "2020-08-17T00:00:00-04:00",
    "actual_end_date": "2020-08-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-08-18T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Duplicate Entry.  Pease refer to the actual entry of Report ID 122375 for the drug shortage info.",
    "fr_comments": "Double entrée. Veuillez vous référer à l'entrée réelle du rapport ID 122375 pour les informations sur la pénurie de médicaments.",
    "en_drug_brand_name": "PLASMA-LYTE A INJECTION",
    "en_drug_common_name": "PLASMA-LYTE A (An Electrolyte Solution) Injection",
    "fr_drug_brand_name": "PLASMA-LYTE A",
    "fr_drug_common_name": "PLASMA-LYTE A (Une solution d’électrolytes) injectable",
    "en_ingredients": "SODIUM CHLORIDE\r\nSODIUM ACETATE\r\nSODIUM GLUCONATE\r\nPOTASSIUM CHLORIDE\r\nMAGNESIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium\r\nAcétate de sodium\r\nGluconate de sodium\r\nChlorure de potassium\r\nChlorure de magnésium",
    "drug_strength": "526MG\r\n368MG\r\n502MG\r\n37MG\r\n30MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1000mL 12EA/CA (JB2544)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122380,
    "drug": {
      "current_status": "MARKETED",
      "id": 8588,
      "drug_code": 60218,
      "updated_date": "2025-05-15T02:31:05-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253479,
          "ingredient": {
            "id": 422,
            "ingredient_code": 1950,
            "en_name": "ACYCLOVIR",
            "fr_name": "Acyclovir (Acyclovir sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02236926",
      "brand_name": "ACYCLOVIR SODIUM INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115506007"
    },
    "created_date": "2020-08-17T14:10:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02236926",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2020-12-31T00:00:00-05:00",
    "actual_start_date": "2020-08-14T00:00:00-04:00",
    "actual_end_date": "2021-01-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2021-01-06T21:48:09-05:00",
    "status": "resolved",
    "en_comments": "Our stock of Acyclovir Sodium Injection 50 mg/mL, 10 mL and 20 mL vials\r\n1/06/21\r\nFresenius Kabi Canada Ltd. is pleased to advise that our Acyclovir Sodium Injection 50 mg/mL SD Vial 10 mL will be available at Ontario distribution centers today, Tuesday, January 5, 2021 and at all other distribution centers by Friday, January 8, 2021. Our Acyclovir Sodium Injection 50 mg/mL SD Vial 20 mL will also be available at Ontario distribution centers on Monday, January 11, 2021 and at all other distribution centers by Friday, January 15, 2021.",
    "fr_comments": "Nos stocks d’Acyclovir sodique injectable à 50 mg / mL en fioles de 10 mL et de 20 mL\r\n1/06/21\r\nAu nom de Fresenius Kabi Canada Ltée, j’ai le plaisir d’annoncer que notre présentation d’Acyclovir sodique injectable à 50 mg/mL en fioles de 10 mL sera disponible dans les centres de distribution de l’Ontario dès aujourd’hui, mardi 5 janvier 2021, et dans tous les autres centres de distribution d’ici le vendredi 8 janvier 2021. Notre présentation d’Acyclovir sodique injectable à 50 mg/mL en fioles DU de 20 mL sera également disponible dans les centres de distribution de l’Ontario dès le lundi 11 janvier 2021 et dans tous les autres centres de distribution d’ici le vendredi 15 janvier 2021.",
    "en_drug_brand_name": "ACYCLOVIR SODIUM INJECTION",
    "en_drug_common_name": "Acyclovir Sodium Injection",
    "fr_drug_brand_name": "Acyclovir sodique injectable",
    "fr_drug_common_name": "Acyclovir sodique injectable",
    "en_ingredients": "ACYCLOVIR",
    "fr_ingredients": "Acyclovir",
    "drug_strength": "50MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "Acyclovir Sodium Injection 50 mg/mL SD Vial 10 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122384,
    "drug": {
      "current_status": "MARKETED",
      "id": 8588,
      "drug_code": 60218,
      "updated_date": "2025-05-15T02:31:05-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253479,
          "ingredient": {
            "id": 422,
            "ingredient_code": 1950,
            "en_name": "ACYCLOVIR",
            "fr_name": "Acyclovir (Acyclovir sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02236926",
      "brand_name": "ACYCLOVIR SODIUM INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115506007"
    },
    "created_date": "2020-08-17T14:12:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02236926",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2020-12-31T00:00:00-05:00",
    "actual_start_date": "2020-08-14T00:00:00-04:00",
    "actual_end_date": "2021-01-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2021-01-12T06:00:02-05:00",
    "status": "resolved",
    "en_comments": "Our stock of Acyclovir Sodium Injection 50 mg/mL, 10 mL and 20 mL vials\r\n1/06/21\r\nFresenius Kabi Canada Ltd. is pleased to advise that our Acyclovir Sodium Injection 50 mg/mL SD Vial 10 mL will be available at Ontario distribution centers today, Tuesday, January 5, 2021 and at all other distribution centers by Friday, January 8, 2021. Our Acyclovir Sodium Injection 50 mg/mL SD Vial 20 mL will also be available at Ontario distribution centers on Monday, January 11, 2021 and at all other distribution centers by Friday, January 15, 2021.",
    "fr_comments": "Nos stocks d’Acyclovir sodique injectable à 50 mg / mL en fioles de 10 mL et de 20 mL\r\n1/06/21\r\nAu nom de Fresenius Kabi Canada Ltée, j’ai le plaisir d’annoncer que notre présentation d’Acyclovir sodique injectable à 50 mg/mL en fioles de 10 mL sera disponible dans les centres de distribution de l’Ontario dès aujourd’hui, mardi 5 janvier 2021, et dans tous les autres centres de distribution d’ici le vendredi 8 janvier 2021. Notre présentation d’Acyclovir sodique injectable à 50 mg/mL en fioles DU de 20 mL sera également disponible dans les centres de distribution de l’Ontario dès le lundi 11 janvier 2021 et dans tous les autres centres de distribution d’ici le vendredi 15 janvier 2021.",
    "en_drug_brand_name": "ACYCLOVIR SODIUM INJECTION",
    "en_drug_common_name": "Acyclovir Sodium Injection",
    "fr_drug_brand_name": "Acyclovir sodique injectable",
    "fr_drug_common_name": "Acyclovir sodique injectable",
    "en_ingredients": "ACYCLOVIR",
    "fr_ingredients": "Acyclovir",
    "drug_strength": "50MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "Acyclovir Sodium Injection 50 mg/mL SD Vial 20 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122442,
    "drug": {
      "current_status": "MARKETED",
      "id": 19248,
      "drug_code": 80498,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256728,
          "ingredient": {
            "id": 2670,
            "ingredient_code": 11854,
            "en_name": "SILDENAFIL",
            "fr_name": "Sildénafil (Citrate de sildénafil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02319500",
      "brand_name": "TEVA-SILDENAFIL R",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136261004"
    },
    "created_date": "2020-08-18T13:37:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02319500",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C02KX",
    "atc_description": "OTHER ANTIHYPERTENSIVES",
    "estimated_end_date": "2021-03-31T00:00:00-04:00",
    "actual_start_date": "2020-08-18T00:00:00-04:00",
    "actual_end_date": "2021-03-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-03-25T15:26:17-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-SILDENAFIL R",
    "en_drug_common_name": "TEVA-SILDENAFIL R 20MG COATED TABS",
    "fr_drug_brand_name": "TEVA-SILDENAFIL R",
    "fr_drug_common_name": "TEVA-SILDENAFIL R 20MG COATED TABS",
    "en_ingredients": "SILDENAFIL",
    "fr_ingredients": "SILDENAFIL",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122465,
    "drug": {
      "current_status": "DORMANT",
      "id": 26426,
      "drug_code": 88761,
      "updated_date": "2025-12-03T02:32:34-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368926,
          "ingredient": {
            "id": 1498,
            "ingredient_code": 9388,
            "en_name": "ALLOPURINOL",
            "fr_name": "Allopurinol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02402777",
      "brand_name": "APO-ALLOPURINOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103654002"
    },
    "created_date": "2020-08-19T14:08:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02402777",
    "company_name": "APOTEX INC",
    "atc_number": "M04AA",
    "atc_description": "ANTIGOUT PREPARATIONS",
    "estimated_end_date": "2021-06-18T00:00:00-04:00",
    "actual_start_date": "2020-08-17T00:00:00-04:00",
    "actual_end_date": "2021-05-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-05-17T12:43:51-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ALLOPURINOL",
    "en_drug_common_name": "ALLOPURINOL",
    "fr_drug_brand_name": "APO-ALLOPURINOL",
    "fr_drug_common_name": "ALLOPURINOL",
    "en_ingredients": "ALLOPURINOL",
    "fr_ingredients": "Allopurinol",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122468,
    "drug": {
      "current_status": "DORMANT",
      "id": 26426,
      "drug_code": 88761,
      "updated_date": "2025-12-03T02:32:34-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368926,
          "ingredient": {
            "id": 1498,
            "ingredient_code": 9388,
            "en_name": "ALLOPURINOL",
            "fr_name": "Allopurinol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02402777",
      "brand_name": "APO-ALLOPURINOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103654002"
    },
    "created_date": "2020-08-19T14:49:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02402777",
    "company_name": "APOTEX INC",
    "atc_number": "M04AA",
    "atc_description": "ANTIGOUT PREPARATIONS",
    "estimated_end_date": "2021-06-18T00:00:00-04:00",
    "actual_start_date": "2020-08-17T00:00:00-04:00",
    "actual_end_date": "2021-05-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-05-17T12:45:25-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ALLOPURINOL",
    "en_drug_common_name": "ALLOPURINOL",
    "fr_drug_brand_name": "APO-ALLOPURINOL",
    "fr_drug_common_name": "ALLOPURINOL",
    "en_ingredients": "ALLOPURINOL",
    "fr_ingredients": "Allopurinol",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122473,
    "drug": {
      "current_status": "MARKETED",
      "id": 61188,
      "drug_code": 95756,
      "updated_date": "2025-12-03T00:33:34-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262795,
          "ingredient": {
            "id": 3466,
            "ingredient_code": 20301,
            "en_name": "DABIGATRAN ETEXILATE",
            "fr_name": "Dabigatran étexilate (Mésilate de dabigatran étexilate)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02468913",
      "brand_name": "APO-DABIGATRAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152467003"
    },
    "created_date": "2020-08-19T14:52:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02468913",
    "company_name": "APOTEX INC",
    "atc_number": "B01AE",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2021-01-22T00:00:00-05:00",
    "actual_start_date": "2020-08-17T00:00:00-04:00",
    "actual_end_date": "2021-01-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-01-26T14:58:34-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DABIGATRAN",
    "en_drug_common_name": "DABIGATRAN",
    "fr_drug_brand_name": "APO-DABIGATRAN",
    "fr_drug_common_name": "DABIGATRAN",
    "en_ingredients": "DABIGATRAN ETEXILATE",
    "fr_ingredients": "DABIGATRAN",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122477,
    "drug": {
      "current_status": "MARKETED",
      "id": 22332,
      "drug_code": 84729,
      "updated_date": "2025-12-03T00:31:43-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257988,
          "ingredient": {
            "id": 2434,
            "ingredient_code": 11485,
            "en_name": "DONEPEZIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de donépézil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02362279",
      "brand_name": "APO-DONEPEZIL",
      "brand_name_fr": "",
      "descriptor": "FILM-COATED",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131548002"
    },
    "created_date": "2020-08-19T14:58:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362279",
    "company_name": "APOTEX INC",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "estimated_end_date": "2020-10-30T00:00:00-04:00",
    "actual_start_date": "2020-08-17T00:00:00-04:00",
    "actual_end_date": "2020-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-26T12:27:49-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DONEPEZIL",
    "en_drug_common_name": "DONEPEZIL",
    "fr_drug_brand_name": "APO-DONEPEZIL",
    "fr_drug_common_name": "DONEPEZIL",
    "en_ingredients": "DONEPEZIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de donépézil",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122480,
    "drug": {
      "current_status": "MARKETED",
      "id": 16784,
      "drug_code": 77741,
      "updated_date": "2025-05-15T02:31:53-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255931,
          "ingredient": {
            "id": 1474,
            "ingredient_code": 156,
            "en_name": "FAMCICLOVIR",
            "fr_name": "Famciclovir"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02292041",
      "brand_name": "APO-FAMCICLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127885001"
    },
    "created_date": "2020-08-19T15:03:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02292041",
    "company_name": "APOTEX INC",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2021-01-29T00:00:00-05:00",
    "actual_start_date": "2020-08-17T00:00:00-04:00",
    "actual_end_date": "2021-01-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-01-11T14:41:17-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-FAMCICLOVIR",
    "en_drug_common_name": "FAMCICLOVIR",
    "fr_drug_brand_name": "APO-FAMCICLOVIR",
    "fr_drug_common_name": "FAMCICLOVIR",
    "en_ingredients": "FAMCICLOVIR",
    "fr_ingredients": "Famciclovir",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122483,
    "drug": {
      "current_status": "MARKETED",
      "id": 6330,
      "drug_code": 43221,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253042,
          "ingredient": {
            "id": 340,
            "ingredient_code": 1253,
            "en_name": "LISINOPRIL",
            "fr_name": "Lisinopril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02217481",
      "brand_name": "APO-LISINOPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9548",
      "number_of_ais": "1",
      "ai_group_no": "0121550003"
    },
    "created_date": "2020-08-19T16:12:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02217481",
    "company_name": "APOTEX INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2020-10-04T00:00:00-04:00",
    "actual_start_date": "2020-08-17T00:00:00-04:00",
    "actual_end_date": "2020-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-05T12:36:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LISINOPRIL TABLET 5 MG",
    "en_drug_common_name": "LISINOPRIL",
    "fr_drug_brand_name": "APO-LISINOPRIL",
    "fr_drug_common_name": "LISINOPRIL",
    "en_ingredients": "LISINOPRIL",
    "fr_ingredients": "Lisinopril",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122486,
    "drug": {
      "current_status": "MARKETED",
      "id": 63374,
      "drug_code": 95701,
      "updated_date": "2025-05-15T02:36:07-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262767,
          "ingredient": {
            "id": 4138,
            "ingredient_code": 16100,
            "en_name": "PERINDOPRIL ARGININE",
            "fr_name": "Périndopril arginine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "14",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8262766,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02468581",
      "brand_name": "APO-PERINDOPRIL/AMLODIPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0257790003"
    },
    "created_date": "2020-08-19T16:15:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02468581",
    "company_name": "APOTEX INC",
    "atc_number": "C09BB",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "estimated_end_date": "2020-09-25T00:00:00-04:00",
    "actual_start_date": "2020-08-17T00:00:00-04:00",
    "actual_end_date": "2020-09-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-09-25T14:21:27-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PERINDOPRIL/AMLODIPINE",
    "en_drug_common_name": "PERINDOPRIL/AMLODIPINE",
    "fr_drug_brand_name": "APO-PERINDOPRIL/AMLODIPINE",
    "fr_drug_common_name": "PERINDOPRIL/AMLODIPINE",
    "en_ingredients": "PERINDOPRIL ARGININE\r\nAMLODIPINE",
    "fr_ingredients": "PERINDOPRIL/AMLODIPINE",
    "drug_strength": "14MG\r\n10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122489,
    "drug": {
      "current_status": "MARKETED",
      "id": 63372,
      "drug_code": 95700,
      "updated_date": "2025-05-15T02:36:07-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262765,
          "ingredient": {
            "id": 4138,
            "ingredient_code": 16100,
            "en_name": "PERINDOPRIL ARGININE",
            "fr_name": "Périndopril arginine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "7",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8262764,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02468573",
      "brand_name": "APO-PERINDOPRIL/AMLODIPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0257790002"
    },
    "created_date": "2020-08-19T16:18:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02468573",
    "company_name": "APOTEX INC",
    "atc_number": "C09BB",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "estimated_end_date": "2020-09-25T00:00:00-04:00",
    "actual_start_date": "2020-08-17T00:00:00-04:00",
    "actual_end_date": "2020-09-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-25T14:21:56-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PERINDOPRIL/AMLODIPINE",
    "en_drug_common_name": "PERINDOPRIL/AMLODIPINE",
    "fr_drug_brand_name": "APO PERINDOPRIL/AMLODIPINE",
    "fr_drug_common_name": "PERINDOPRIL/AMLODIPINE",
    "en_ingredients": "PERINDOPRIL ARGININE\r\nAMLODIPINE",
    "fr_ingredients": "PERINDOPRIL/AMLODIPINE",
    "drug_strength": "7MG\r\n5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122492,
    "drug": {
      "current_status": "DORMANT",
      "id": 18668,
      "drug_code": 79944,
      "updated_date": "2025-05-15T06:55:37-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368175,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02313928",
      "brand_name": "APO-QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858002"
    },
    "created_date": "2020-08-19T16:21:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02313928",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2020-09-02T00:00:00-04:00",
    "actual_start_date": "2020-08-17T00:00:00-04:00",
    "actual_end_date": "2020-09-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-04T17:46:47-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-QUETIAPINE",
    "en_drug_common_name": "QUETIAPINE",
    "fr_drug_brand_name": "APO-QUETIAPINE",
    "fr_drug_common_name": "QUETIAPINE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122495,
    "drug": {
      "current_status": "DORMANT",
      "id": 18670,
      "drug_code": 79945,
      "updated_date": "2025-05-15T06:55:37-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368176,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02313936",
      "brand_name": "APO-QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858003"
    },
    "created_date": "2020-08-19T16:25:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02313936",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2021-06-03T00:00:00-04:00",
    "actual_start_date": "2021-04-12T00:00:00-04:00",
    "actual_end_date": "2021-05-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-05-31T15:50:10-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-QUETIAPINE",
    "en_drug_common_name": "QUETIAPINE",
    "fr_drug_brand_name": "APO-QUETIAPINE",
    "fr_drug_common_name": "QUETIAPINE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122497,
    "drug": {
      "current_status": "DORMANT",
      "id": 18670,
      "drug_code": 79945,
      "updated_date": "2025-05-15T06:55:37-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368176,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02313936",
      "brand_name": "APO-QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858003"
    },
    "created_date": "2020-08-19T16:25:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02313936",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2020-09-06T00:00:00-04:00",
    "actual_start_date": "2020-08-17T00:00:00-04:00",
    "actual_end_date": "2020-09-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-04T17:55:00-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-QUETIAPINE",
    "en_drug_common_name": "QUETIAPINE",
    "fr_drug_brand_name": "APO-QUETIAPINE",
    "fr_drug_common_name": "QUETIAPINE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122502,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 28704,
      "drug_code": 90829,
      "updated_date": "2025-05-15T04:22:21-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8354560,
          "ingredient": {
            "id": 786,
            "ingredient_code": 93,
            "en_name": "CIPROFLOXACIN",
            "fr_name": "Ciprofloxacine (Chlorhydrate de ciprofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "750",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02423588",
      "brand_name": "MINT-CIPROFLOX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123207002"
    },
    "created_date": "2020-08-19T17:13:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02423588",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "J01MA",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "hc_updated_date": "2022-06-06T16:53:06-04:00",
    "estimated_end_date": "2021-10-30T00:00:00-04:00",
    "actual_start_date": "2020-08-19T00:00:00-04:00",
    "actual_end_date": "2022-03-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-06T16:53:09-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-CIPROFLOX",
    "en_drug_common_name": "Ciprofloxacin",
    "fr_drug_brand_name": "Mint-Ciproflox",
    "fr_drug_common_name": "Ciprofloxacin",
    "en_ingredients": "CIPROFLOXACIN",
    "fr_ingredients": "Ciprofloxacine",
    "drug_strength": "750MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 count bottles",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122507,
    "drug": {
      "current_status": "MARKETED",
      "id": 29402,
      "drug_code": 91415,
      "updated_date": "2025-05-15T02:34:29-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260668,
          "ingredient": {
            "id": 2658,
            "ingredient_code": 11847,
            "en_name": "CITALOPRAM",
            "fr_name": "Citalopram (Bromhydrate de citalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02429705",
      "brand_name": "MINT-CITALOPRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136243001"
    },
    "created_date": "2020-08-19T17:21:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02429705",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2020-10-30T00:00:00-04:00",
    "actual_start_date": "2020-08-19T00:00:00-04:00",
    "actual_end_date": "2020-11-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-11T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-CITALOPRAM",
    "en_drug_common_name": "Citalopram",
    "fr_drug_brand_name": "Mint-Citalopram",
    "fr_drug_common_name": "Citalopram",
    "en_ingredients": "CITALOPRAM",
    "fr_ingredients": "Citalopram",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 count bottles",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122510,
    "drug": {
      "current_status": "DORMANT",
      "id": 28474,
      "drug_code": 90597,
      "updated_date": "2025-05-15T06:55:54-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369079,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02421348",
      "brand_name": "MINT-RAMIPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122858005"
    },
    "created_date": "2020-08-19T17:27:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02421348",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "anticipated_start_date": "2020-08-19T00:00:00-04:00",
    "estimated_end_date": "2020-12-31T00:00:00-05:00",
    "actual_end_date": "2020-12-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-01-11T17:21:08-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-RAMIPRIL",
    "en_drug_common_name": "Ramipril",
    "fr_drug_brand_name": "Mint-Ramipril",
    "fr_drug_common_name": "Ramipril",
    "en_ingredients": "RAMIPRIL",
    "fr_ingredients": "Ramipril",
    "drug_strength": "15.0MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 count bottles",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122513,
    "drug": {
      "current_status": "MARKETED",
      "id": 22112,
      "drug_code": 84482,
      "updated_date": "2025-05-15T02:32:51-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257923,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02359839",
      "brand_name": "MINT-RISPERIDON",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332002"
    },
    "created_date": "2020-08-19T17:38:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02359839",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2020-09-18T00:00:00-04:00",
    "actual_start_date": "2020-08-19T00:00:00-04:00",
    "actual_end_date": "2020-09-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-09-21T19:55:19-04:00",
    "status": "resolved",
    "en_comments": "In Transit delay due to strike.",
    "fr_comments": "In transit delay due to strike.",
    "en_drug_brand_name": "MINT-RISPERIDON",
    "en_drug_common_name": "Risperidon",
    "fr_drug_brand_name": "Mint-Ramipril",
    "fr_drug_common_name": "Ramipril",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone",
    "drug_strength": "3.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 count bottles",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122516,
    "drug": {
      "current_status": "MARKETED",
      "id": 22114,
      "drug_code": 84483,
      "updated_date": "2025-05-15T02:32:51-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257924,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02359847",
      "brand_name": "MINT-RISPERIDON",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332005"
    },
    "created_date": "2020-08-19T17:42:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02359847",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2020-09-18T00:00:00-04:00",
    "actual_start_date": "2020-08-19T00:00:00-04:00",
    "actual_end_date": "2020-09-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-09-21T19:55:47-04:00",
    "status": "resolved",
    "en_comments": "In Transit delay due to strike.",
    "fr_comments": "In Transit delay due to strike",
    "en_drug_brand_name": "MINT-RISPERIDON",
    "en_drug_common_name": "Risperidon",
    "fr_drug_brand_name": "Mint-Ramipril",
    "fr_drug_common_name": "Ramipril",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone",
    "drug_strength": "4.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 count bottles",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122521,
    "drug": {
      "current_status": "MARKETED",
      "id": 65345,
      "drug_code": 89481,
      "updated_date": "2025-05-15T02:34:00-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259832,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02410141",
      "brand_name": "MINT-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783001"
    },
    "created_date": "2020-08-19T18:27:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02410141",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2020-09-30T00:00:00-04:00",
    "actual_start_date": "2020-08-19T00:00:00-04:00",
    "actual_end_date": "2020-10-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-10-27T12:44:30-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-OLANZAPINE",
    "en_drug_common_name": "Olanzapine",
    "fr_drug_brand_name": "Mint-Olanzapine",
    "fr_drug_common_name": "Olanzapine",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 count bottles",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122524,
    "drug": {
      "current_status": "MARKETED",
      "id": 65347,
      "drug_code": 89482,
      "updated_date": "2025-05-15T02:34:00-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259833,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02410168",
      "brand_name": "MINT-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783003"
    },
    "created_date": "2020-08-19T18:28:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02410168",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2020-08-19T00:00:00-04:00",
    "estimated_end_date": "2020-09-30T00:00:00-04:00",
    "actual_end_date": "2020-10-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-27T12:45:26-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-OLANZAPINE",
    "en_drug_common_name": "Olanzapine",
    "fr_drug_brand_name": "Mint-Olanzapine",
    "fr_drug_common_name": "Olanzapine",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 count bottles",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122527,
    "drug": {
      "current_status": "MARKETED",
      "id": 65351,
      "drug_code": 89484,
      "updated_date": "2025-05-15T02:34:00-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259835,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02410184",
      "brand_name": "MINT-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783002"
    },
    "created_date": "2020-08-19T18:30:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02410184",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2020-09-30T00:00:00-04:00",
    "actual_start_date": "2020-08-19T00:00:00-04:00",
    "actual_end_date": "2020-10-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-27T12:44:58-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-OLANZAPINE",
    "en_drug_common_name": "Olanzapine",
    "fr_drug_brand_name": "Mint-Olanzapine",
    "fr_drug_common_name": "Olanzapine",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 count bottles",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122560,
    "drug": {
      "current_status": "MARKETED",
      "id": 3956,
      "drug_code": 19601,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252522,
          "ingredient": {
            "id": 1414,
            "ingredient_code": 5325,
            "en_name": "LEVOTHYROXINE SODIUM",
            "fr_name": "Lévothyroxine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02172100",
      "brand_name": "SYNTHROID",
      "brand_name_fr": "",
      "descriptor": "TAB 100MCG",
      "pediatric_flag": false,
      "accession_number": "81898",
      "number_of_ais": "1",
      "ai_group_no": "0107794024"
    },
    "created_date": "2020-08-20T13:11:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02172100",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "H03AA",
    "atc_description": "THYROID PREPARATIONS",
    "anticipated_start_date": "2020-12-09T00:00:00-05:00",
    "estimated_end_date": "2021-01-05T00:00:00-05:00",
    "actual_end_date": "2020-10-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-14T11:49:39-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "SYNTHROID",
    "en_drug_common_name": "LEVOTHYROXINE",
    "fr_drug_brand_name": "SYNTHROID",
    "fr_drug_common_name": "LEVOTHYROXINE",
    "en_ingredients": "LEVOTHYROXINE SODIUM",
    "fr_ingredients": "Lévothyroxine sodique",
    "drug_strength": "100MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90BT, 1000BT",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122563,
    "drug": {
      "current_status": "MARKETED",
      "id": 3954,
      "drug_code": 19600,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252521,
          "ingredient": {
            "id": 1414,
            "ingredient_code": 5325,
            "en_name": "LEVOTHYROXINE SODIUM",
            "fr_name": "Lévothyroxine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "175",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02172135",
      "brand_name": "SYNTHROID",
      "brand_name_fr": "",
      "descriptor": "TAB 175MCG",
      "pediatric_flag": false,
      "accession_number": "81897",
      "number_of_ais": "1",
      "ai_group_no": "0107794017"
    },
    "created_date": "2020-08-20T13:13:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02172135",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "H03AA",
    "atc_description": "THYROID PREPARATIONS",
    "estimated_end_date": "2020-09-01T00:00:00-04:00",
    "actual_start_date": "2020-08-14T00:00:00-04:00",
    "actual_end_date": "2020-09-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-02T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SYNTHROID",
    "en_drug_common_name": "LEVOTHYROXINE",
    "fr_drug_brand_name": "SYNTHROID",
    "fr_drug_common_name": "LEVOTHYROXINE",
    "en_ingredients": "LEVOTHYROXINE SODIUM",
    "fr_ingredients": "Lévothyroxine sodique",
    "drug_strength": "175MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90BT, 1000BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122566,
    "drug": {
      "current_status": "MARKETED",
      "id": 762,
      "drug_code": 11752,
      "updated_date": "2025-05-15T02:30:51-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251565,
          "ingredient": {
            "id": 490,
            "ingredient_code": 1212,
            "en_name": "FLUVOXAMINE MALEATE",
            "fr_name": "Maléate de fluvoxamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01919342",
      "brand_name": "LUVOX",
      "brand_name_fr": "LUVOX",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "72652",
      "number_of_ais": "1",
      "ai_group_no": "0122450002"
    },
    "created_date": "2020-08-20T13:20:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01919342",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2020-09-02T00:00:00-04:00",
    "estimated_end_date": "2020-09-15T00:00:00-04:00",
    "actual_end_date": "2020-09-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-01T13:34:29-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "LUVOX",
    "en_drug_common_name": "FLUVOXAMINE MALEATE",
    "fr_drug_brand_name": "LUVOX",
    "fr_drug_common_name": "FLUVOXAMINE MALEATE",
    "en_ingredients": "FLUVOXAMINE MALEATE",
    "fr_ingredients": "Maléate de fluvoxamine",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "2x15BL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122573,
    "drug": {
      "current_status": "MARKETED",
      "id": 26524,
      "drug_code": 88832,
      "updated_date": "2025-05-15T02:33:53-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259575,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02403536",
      "brand_name": "5% DEXTROSE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0102181006"
    },
    "created_date": "2020-08-20T14:33:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02403536",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B05BA",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2020-08-19T00:00:00-04:00",
    "estimated_end_date": "2020-09-01T00:00:00-04:00",
    "actual_start_date": "2020-08-19T00:00:00-04:00",
    "actual_end_date": "2020-08-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-09-01T05:00:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DEXTROSE 5% INJECTION",
    "en_drug_common_name": "Dextrose 5% Injection 1000ml freeflex bag",
    "fr_drug_brand_name": "DEXTROSE 5% INJECTION",
    "fr_drug_common_name": "Dextrose 5% Injection 1000ml freeflex bag",
    "en_ingredients": "DEXTROSE",
    "fr_ingredients": "Dextrose",
    "drug_strength": "50MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1000ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122685,
    "drug": {
      "current_status": "MARKETED",
      "id": 4692,
      "drug_code": 2447,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250414,
          "ingredient": {
            "id": 564,
            "ingredient_code": 10091,
            "en_name": "FUROSEMIDE",
            "fr_name": "Furosémide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00337749",
      "brand_name": "TEVA-FUROSEMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "49660",
      "number_of_ais": "1",
      "ai_group_no": "0101944001"
    },
    "created_date": "2020-08-20T19:57:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00337749",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C03CA",
    "atc_description": "HIGH-CEILING DIURETICS",
    "estimated_end_date": "2021-01-31T00:00:00-05:00",
    "actual_start_date": "2020-08-20T00:00:00-04:00",
    "actual_end_date": "2020-12-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-12-17T19:20:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-FUROSEMIDE",
    "en_drug_common_name": "TEVA-FUROSEMIDE 40MG TABLETS",
    "fr_drug_brand_name": "TEVA-FUROSEMIDE",
    "fr_drug_common_name": "TEVA-FUROSEMIDE 40MG TABLETS",
    "en_ingredients": "FUROSEMIDE",
    "fr_ingredients": "Furosémide",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100,1000",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122688,
    "drug": {
      "current_status": "MARKETED",
      "id": 8420,
      "drug_code": 5859,
      "updated_date": "2025-05-15T02:30:35-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250843,
          "ingredient": {
            "id": 26,
            "ingredient_code": 10146,
            "en_name": "HALOPERIDOL",
            "fr_name": "Halopéridol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00363650",
      "brand_name": "TEVA-HALOPERIDOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "61644",
      "number_of_ais": "1",
      "ai_group_no": "0101774001"
    },
    "created_date": "2020-08-20T19:58:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00363650",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N05AD",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2020-10-31T00:00:00-04:00",
    "actual_start_date": "2020-08-20T00:00:00-04:00",
    "actual_end_date": "2020-11-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-07T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-HALOPERIDOL",
    "en_drug_common_name": "TEVA-HALOPERIDOL 5MG TABLETS",
    "fr_drug_brand_name": "TEVA-HALOPERIDOL",
    "fr_drug_common_name": "TEVA-HALOPERIDOL 5MG TABLETS",
    "en_ingredients": "HALOPERIDOL",
    "fr_ingredients": "Halopéridol",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122693,
    "drug": {
      "current_status": "MARKETED",
      "id": 1594,
      "drug_code": 13437,
      "updated_date": "2025-05-15T02:30:53-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251765,
          "ingredient": {
            "id": 886,
            "ingredient_code": 7558,
            "en_name": "CLOBETASOL PROPIONATE",
            "fr_name": "Propionate de clobétasol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01910272",
      "brand_name": "TEVA-CLOBETASOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74824",
      "number_of_ais": "1",
      "ai_group_no": "0110995001"
    },
    "created_date": "2020-08-20T20:00:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01910272",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "D07AD",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2020-12-31T00:00:00-05:00",
    "actual_start_date": "2020-08-20T00:00:00-04:00",
    "actual_end_date": "2020-12-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-12-17T19:20:26-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CLOBETASOL",
    "en_drug_common_name": "TEVA-CLOBETASOL 0.05% CREAM",
    "fr_drug_brand_name": "TEVA-CLOBETASOL",
    "fr_drug_common_name": "TEVA-CLOBETASOL 0.05% CREAM",
    "en_ingredients": "CLOBETASOL PROPIONATE",
    "fr_ingredients": "Propionate de clobétasol",
    "drug_strength": "0.05%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "50",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122696,
    "drug": {
      "current_status": "MARKETED",
      "id": 3912,
      "drug_code": 19534,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252508,
          "ingredient": {
            "id": 1568,
            "ingredient_code": 11180,
            "en_name": "CEFAZOLIN",
            "fr_name": "Céfazoline (Céfazoline sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        }
      ],
      "din": "02108135",
      "brand_name": "CEFAZOLIN FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81831",
      "number_of_ais": "1",
      "ai_group_no": "0109442003"
    },
    "created_date": "2020-08-20T20:01:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02108135",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01DB",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2020-10-31T00:00:00-04:00",
    "actual_start_date": "2020-08-20T00:00:00-04:00",
    "actual_end_date": "2020-10-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-08T18:52:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CEFAZOLIN FOR INJECTION",
    "en_drug_common_name": "CEFAZOLIN SODIUM INJ",
    "fr_drug_brand_name": "CEFAZOLIN SODIUM",
    "fr_drug_common_name": "CEFAZOLIN SODIUM INJ",
    "en_ingredients": "CEFAZOLIN",
    "fr_ingredients": "CEFAZOLIN SODIUM",
    "drug_strength": "10G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122699,
    "drug": {
      "current_status": "MARKETED",
      "id": 3200,
      "drug_code": 18189,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252258,
          "ingredient": {
            "id": 946,
            "ingredient_code": 1939,
            "en_name": "TRAZODONE HYDROCHLORIDE",
            "fr_name": "Chlohydrate de trazodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02144298",
      "brand_name": "TEVA-TRAZODONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80411",
      "number_of_ais": "1",
      "ai_group_no": "0115713003"
    },
    "created_date": "2020-08-20T20:01:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02144298",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2020-09-30T00:00:00-04:00",
    "actual_start_date": "2020-08-20T00:00:00-04:00",
    "actual_end_date": "2020-09-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-03T18:03:10-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-TRAZODONE",
    "en_drug_common_name": "TEVA-TRAZODONE 150MG COMP TABS",
    "fr_drug_brand_name": "TEVA-TRAZODONE 150MG",
    "fr_drug_common_name": "TEVA-TRAZODONE 150MG COMP TABS",
    "en_ingredients": "TRAZODONE HYDROCHLORIDE",
    "fr_ingredients": "Chlohydrate de trazodone",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122702,
    "drug": {
      "current_status": "MARKETED",
      "id": 10308,
      "drug_code": 65371,
      "updated_date": "2025-12-03T00:30:44-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253899,
          "ingredient": {
            "id": 138,
            "ingredient_code": 8551,
            "en_name": "CLINDAMYCIN",
            "fr_name": "Clindamycine (Chlorhydrate de clindamycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02241709",
      "brand_name": "TEVA-CLINDAMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105830002"
    },
    "created_date": "2020-08-20T20:04:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241709",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01FF",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "estimated_end_date": "2021-02-28T00:00:00-05:00",
    "actual_start_date": "2020-08-20T00:00:00-04:00",
    "actual_end_date": "2021-01-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-01-28T18:36:14-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CLINDAMYCIN",
    "en_drug_common_name": "TEVA-CLINDAMYCIN 150MG CAPSULES",
    "fr_drug_brand_name": "TEVA-CLINDAMYCIN",
    "fr_drug_common_name": "TEVA-CLINDAMYCIN 150MG CAPSULES",
    "en_ingredients": "CLINDAMYCIN",
    "fr_ingredients": "CLINDAMYCIN",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122705,
    "drug": {
      "current_status": "MARKETED",
      "id": 13000,
      "drug_code": 72255,
      "updated_date": "2025-05-15T02:31:28-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254749,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247945",
      "brand_name": "TEVA-RAMIPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122858004"
    },
    "created_date": "2020-08-20T20:05:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247945",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2020-09-30T00:00:00-04:00",
    "actual_start_date": "2020-08-20T00:00:00-04:00",
    "actual_end_date": "2020-10-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-08T18:52:29-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-RAMIPRIL",
    "en_drug_common_name": "TEVA-RAMIPRIL 2.5MG CAPSULES",
    "fr_drug_brand_name": "TEVA-RAMIPRIL",
    "fr_drug_common_name": "TEVA-RAMIPRIL CAPSULES",
    "en_ingredients": "RAMIPRIL",
    "fr_ingredients": "Ramipril",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122712,
    "drug": {
      "current_status": "MARKETED",
      "id": 16364,
      "drug_code": 77145,
      "updated_date": "2025-05-15T02:31:49-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255830,
          "ingredient": {
            "id": 422,
            "ingredient_code": 1950,
            "en_name": "ACYCLOVIR",
            "fr_name": "Acyclovir (Acyclovir sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02285967",
      "brand_name": "TEVA-ACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115506004"
    },
    "created_date": "2020-08-20T20:09:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02285967",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "actual_start_date": "2020-08-20T00:00:00-04:00",
    "actual_end_date": "2024-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-04-29T13:46:53-04:00",
    "status": "resolved",
    "en_comments": "Discontinued",
    "fr_comments": "Discontinued",
    "en_drug_brand_name": "TEVA-ACYCLOVIR",
    "en_drug_common_name": "TEVA-ACYCLOVIR 400MG TABLETS",
    "fr_drug_brand_name": "TEVA-ACYCLOVIR",
    "fr_drug_common_name": "TEVA-ACYCLOVIR 400MG TABLETS",
    "en_ingredients": "ACYCLOVIR",
    "fr_ingredients": "Acyclovir",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122717,
    "drug": {
      "current_status": "MARKETED",
      "id": 19116,
      "drug_code": 80371,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256697,
          "ingredient": {
            "id": 3198,
            "ingredient_code": 13585,
            "en_name": "ESCITALOPRAM",
            "fr_name": "Escitalopram (Oxalate d'escitalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02318202",
      "brand_name": "TEVA-ESCITALOPRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150435004"
    },
    "created_date": "2020-08-20T20:10:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02318202",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2020-11-30T00:00:00-05:00",
    "actual_start_date": "2020-08-20T00:00:00-04:00",
    "actual_end_date": "2020-09-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-24T17:39:30-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ESCITALOPRAM",
    "en_drug_common_name": "TEVA-ESCITALOPRAM 20MG TABLETS",
    "fr_drug_brand_name": "TEVA-ESCITALOPRAM",
    "fr_drug_common_name": "TEVA-ESCITALOPRAM 20MG TABLETS",
    "en_ingredients": "ESCITALOPRAM",
    "fr_ingredients": "Escitalopram",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122720,
    "drug": {
      "current_status": "MARKETED",
      "id": 25644,
      "drug_code": 88053,
      "updated_date": "2025-05-15T02:33:42-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259262,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02395444",
      "brand_name": "TEVA-QUETIAPINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858006"
    },
    "created_date": "2020-08-20T20:26:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02395444",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2020-11-30T00:00:00-05:00",
    "actual_start_date": "2020-08-20T00:00:00-04:00",
    "actual_end_date": "2020-09-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-03T18:03:44-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-QUETIAPINE XR",
    "en_drug_common_name": "TEVA-QUETIAPINE XR 50MG TABLETS",
    "fr_drug_brand_name": "TEVA-QUETIAPINE XR",
    "fr_drug_common_name": "TEVA-QUETIAPINE XR 50MG TABLETS",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122723,
    "drug": {
      "current_status": "MARKETED",
      "id": 30558,
      "drug_code": 92602,
      "updated_date": "2025-05-15T02:34:48-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261209,
          "ingredient": {
            "id": 3162,
            "ingredient_code": 13352,
            "en_name": "CINACALCET",
            "fr_name": "Cinacalcet (Chlorhydrate de cinacalcet)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02441632",
      "brand_name": "TEVA-CINACALCET",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150282002"
    },
    "created_date": "2020-08-20T20:27:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02441632",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "H05BX",
    "atc_description": "ANTI-PARATHYROID HORMONES",
    "actual_start_date": "2020-08-20T00:00:00-04:00",
    "actual_end_date": "2021-03-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-03-18T15:18:47-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CINACALCET",
    "en_drug_common_name": "TEVA-CINACALCET 60MG TABS",
    "fr_drug_brand_name": "TEVA-CINACALCET",
    "fr_drug_common_name": "TEVA-CINACALCET 60MG TABS",
    "en_ingredients": "CINACALCET",
    "fr_ingredients": "CINACALCET",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122787,
    "drug": {
      "current_status": "MARKETED",
      "id": 30784,
      "drug_code": 92871,
      "updated_date": "2025-12-03T00:32:52-05:00",
      "company": {
        "id": 192,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 3617,
        "mfr_code": "BOE07",
        "name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "5180 SOUTH SERVICE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BURLINGTON",
        "postal_code": "L7L 5H4",
        "post_office_box": "",
        "contact_information": "1800 263 2425"
      },
      "drug_ingredients": [
        {
          "id": 8261356,
          "ingredient": {
            "id": 4090,
            "ingredient_code": 22629,
            "en_name": "EMPAGLIFLOZIN",
            "fr_name": "EMPAGLIFLOZINE"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02443937",
      "brand_name": "JARDIANCE",
      "brand_name_fr": "JARDIANCE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0157150001"
    },
    "created_date": "2020-08-21T21:29:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02443937",
    "company_name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
    "atc_number": "A10BK",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2020-08-26T00:00:00-04:00",
    "estimated_end_date": "2020-08-31T00:00:00-04:00",
    "actual_start_date": "2020-08-27T00:00:00-04:00",
    "actual_end_date": "2020-09-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-12T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Jardiance (empagliflozin) 10mg 9x10s remain available",
    "fr_comments": "Jardiance (empagliflozine) 10mg 9x10s restent disponibles",
    "en_drug_brand_name": "JARDIANCE",
    "en_drug_common_name": "Jardiance 30's",
    "fr_drug_brand_name": "JARDIANCE",
    "fr_drug_common_name": "Jardiance 30's",
    "en_ingredients": "EMPAGLIFLOZIN",
    "fr_ingredients": "EMPAGLIFLOZINE",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30s",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122896,
    "drug": {
      "current_status": "MARKETED",
      "id": 5098,
      "drug_code": 3089,
      "updated_date": "2025-05-15T02:30:28-04:00",
      "company": {
        "id": 366,
        "created_date": "2017-03-09T13:22:43-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 14115,
        "mfr_code": "",
        "name": "XEDITON PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "402",
        "street_name": "2020 WINSTON PARK DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 6X7",
        "post_office_box": "",
        "contact_information": "george.gafrey@xediton.com"
      },
      "drug_ingredients": [
        {
          "id": 8250484,
          "ingredient": {
            "id": 284,
            "ingredient_code": 2144,
            "en_name": "PINDOLOL",
            "fr_name": "Pindolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00417270",
      "brand_name": "VISKEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "52790",
      "number_of_ais": "1",
      "ai_group_no": "0112362001"
    },
    "created_date": "2020-08-24T20:32:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00417270",
    "company_name": "ARALEZ PHARMACEUTICALS CANADA INC",
    "atc_number": "C07AA",
    "atc_description": "BETA BLOCKING AGENTS",
    "actual_start_date": "2020-08-21T00:00:00-04:00",
    "actual_end_date": "2021-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-15T21:51:42-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VISKEN",
    "en_drug_common_name": "pindolol",
    "fr_drug_brand_name": "Visken",
    "fr_drug_common_name": "pindolol",
    "en_ingredients": "PINDOLOL",
    "fr_ingredients": "Pindolol",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122899,
    "drug": {
      "current_status": "MARKETED",
      "id": 5102,
      "drug_code": 3091,
      "updated_date": "2025-05-15T02:30:28-04:00",
      "company": {
        "id": 366,
        "created_date": "2017-03-09T13:22:43-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 14115,
        "mfr_code": "",
        "name": "XEDITON PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "402",
        "street_name": "2020 WINSTON PARK DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 6X7",
        "post_office_box": "",
        "contact_information": "george.gafrey@xediton.com"
      },
      "drug_ingredients": [
        {
          "id": 8250485,
          "ingredient": {
            "id": 284,
            "ingredient_code": 2144,
            "en_name": "PINDOLOL",
            "fr_name": "Pindolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00443174",
      "brand_name": "VISKEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "52792",
      "number_of_ais": "1",
      "ai_group_no": "0112362003"
    },
    "created_date": "2020-08-24T20:33:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00443174",
    "company_name": "ARALEZ PHARMACEUTICALS CANADA INC",
    "atc_number": "C07AA",
    "atc_description": "BETA BLOCKING AGENTS",
    "actual_start_date": "2020-08-21T00:00:00-04:00",
    "actual_end_date": "2021-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-15T21:50:40-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VISKEN",
    "en_drug_common_name": "pindolol",
    "fr_drug_brand_name": "Visken",
    "fr_drug_common_name": "pindolol",
    "en_ingredients": "PINDOLOL",
    "fr_ingredients": "Pindolol",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122935,
    "drug": {
      "current_status": "MARKETED",
      "id": 25688,
      "drug_code": 88080,
      "updated_date": "2025-05-15T02:33:43-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8259283,
          "ingredient": {
            "id": 2382,
            "ingredient_code": 11384,
            "en_name": "TOPIRAMATE",
            "fr_name": "Topiramate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02395746",
      "brand_name": "ACH-TOPIRAMATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132938002"
    },
    "created_date": "2020-08-26T12:25:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02395746",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2020-08-25T00:00:00-04:00",
    "actual_start_date": "2020-08-25T00:00:00-04:00",
    "actual_end_date": "2021-03-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-03-06T06:00:01-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ACH-TOPIRAMATE",
    "en_drug_common_name": "TOPIRAMATE",
    "fr_drug_brand_name": "ACH-Topiramate",
    "fr_drug_common_name": "Topiramate",
    "en_ingredients": "TOPIRAMATE",
    "fr_ingredients": "Topiramate",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122940,
    "drug": {
      "current_status": "MARKETED",
      "id": 25686,
      "drug_code": 88079,
      "updated_date": "2025-05-15T02:33:43-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8259282,
          "ingredient": {
            "id": 2382,
            "ingredient_code": 11384,
            "en_name": "TOPIRAMATE",
            "fr_name": "Topiramate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02395738",
      "brand_name": "ACH-TOPIRAMATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132938001"
    },
    "created_date": "2020-08-26T12:28:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02395738",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2020-08-26T00:00:00-04:00",
    "actual_start_date": "2020-08-26T00:00:00-04:00",
    "actual_end_date": "2021-03-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-03-06T06:00:01-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ACH-TOPIRAMATE",
    "en_drug_common_name": "TOPIRAMATE",
    "fr_drug_brand_name": "ACH-Topiramate",
    "fr_drug_common_name": "Topiramate",
    "en_ingredients": "TOPIRAMATE",
    "fr_ingredients": "Topiramate",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122943,
    "drug": {
      "current_status": "MARKETED",
      "id": 24104,
      "drug_code": 86732,
      "updated_date": "2025-05-15T02:33:14-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8258675,
          "ingredient": {
            "id": 2950,
            "ingredient_code": 13353,
            "en_name": "ALENDRONIC ACID",
            "fr_name": "Acide alendronique (Alendronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02381478",
      "brand_name": "ACH-ALENDRONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150323004"
    },
    "created_date": "2020-08-26T12:30:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02381478",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "actual_start_date": "2020-08-28T00:00:00-04:00",
    "actual_end_date": "2021-01-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-01-21T13:38:49-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ACH-ALENDRONATE",
    "en_drug_common_name": "ALENDRONATE SODIUM",
    "fr_drug_brand_name": "ACH-Alendronate",
    "fr_drug_common_name": "ALENDRONATE SODIUM",
    "en_ingredients": "ALENDRONIC ACID",
    "fr_ingredients": "ALENDRONATE",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "28",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122948,
    "drug": {
      "current_status": "MARKETED",
      "id": 62759,
      "drug_code": 92329,
      "updated_date": "2025-12-03T00:32:46-05:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8261055,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02438917",
      "brand_name": "ACH-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963004"
    },
    "created_date": "2020-08-26T12:34:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02438917",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2020-08-27T00:00:00-04:00",
    "actual_end_date": "2021-02-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-02-24T13:43:43-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ACH-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "ACH-Rosuvastatin",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122955,
    "drug": {
      "current_status": "MARKETED",
      "id": 23128,
      "drug_code": 85702,
      "updated_date": "2025-05-15T02:33:02-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258355,
          "ingredient": {
            "id": 2658,
            "ingredient_code": 11847,
            "en_name": "CITALOPRAM",
            "fr_name": "Citalopram (Bromhydrate de citalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02371901",
      "brand_name": "MAR-CITALOPRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136243002"
    },
    "created_date": "2020-08-26T13:06:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02371901",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2020-08-26T00:00:00-04:00",
    "estimated_end_date": "2020-10-19T00:00:00-04:00",
    "actual_start_date": "2020-08-26T00:00:00-04:00",
    "actual_end_date": "2020-10-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-10-19T12:57:57-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-CITALOPRAM",
    "en_drug_common_name": "CITALOPRAM",
    "fr_drug_brand_name": "MAR- CITALOPRAM",
    "fr_drug_common_name": "CITALOPRAM",
    "en_ingredients": "CITALOPRAM",
    "fr_ingredients": "CITALOPRAM",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 Tablet",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122962,
    "drug": {
      "current_status": "MARKETED",
      "id": 97188,
      "drug_code": 81495,
      "updated_date": "2020-04-03T06:51:30-04:00",
      "company": {
        "id": 604,
        "created_date": "2017-03-09T13:22:58-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 6996,
        "mfr_code": "BEW08",
        "name": "BRACCO IMAGING CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11065 BOUL. L-H LAFONTAINE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "VILLE D'ANJOU",
        "postal_code": "H1J 2Z4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257086,
          "ingredient": {
            "id": 35910,
            "ingredient_code": 20493,
            "en_name": "MEBROFENIN",
            "fr_name": "Mébrofénine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "45",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02329263",
      "brand_name": "CHOLETEC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152621001"
    },
    "created_date": "2020-08-26T13:50:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02329263",
    "company_name": "BRACCO IMAGING CANADA",
    "atc_number": "V09DA",
    "hc_updated_date": "2022-04-14T15:27:02-04:00",
    "anticipated_start_date": "2020-08-25T00:00:00-04:00",
    "estimated_end_date": "2022-03-24T00:00:00-04:00",
    "actual_start_date": "2020-08-25T00:00:00-04:00",
    "actual_end_date": "2022-05-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-05-31T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Disruption of the manufacturing operations at the CMO level related to Covid-19",
    "en_drug_brand_name": "CHOLETEC",
    "en_drug_common_name": "MEBROFENIN",
    "fr_drug_brand_name": "CHOLETEC",
    "fr_drug_common_name": "MEBROFENIN",
    "fr_ingredients": "MEBROFENIN",
    "drug_strength": "45MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "kit of 10 vials",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122967,
    "drug": {
      "current_status": "MARKETED",
      "id": 15062,
      "drug_code": 75494,
      "updated_date": "2025-05-15T02:31:40-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8255386,
          "ingredient": {
            "id": 2948,
            "ingredient_code": 12597,
            "en_name": "GLIMEPIRIDE",
            "fr_name": "Glimépiride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02269589",
      "brand_name": "SANDOZ GLIMEPIRIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0146247001"
    },
    "created_date": "2020-08-26T15:05:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02269589",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A10BB",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2020-10-16T00:00:00-04:00",
    "actual_start_date": "2020-08-21T00:00:00-04:00",
    "actual_end_date": "2020-10-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-10-19T12:08:35-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ GLIMEPIRIDE",
    "en_drug_common_name": "SANDOZ GLIMEPIRIDE",
    "fr_drug_brand_name": "SANDOZ GLIMEPIRIDE",
    "fr_drug_common_name": "SANDOZ GLIMEPIRIDE",
    "en_ingredients": "GLIMEPIRIDE",
    "fr_ingredients": "Glimépiride",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 TAB CA",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122970,
    "drug": {
      "current_status": "DORMANT",
      "id": 17776,
      "drug_code": 78843,
      "updated_date": "2025-05-15T06:55:36-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8368115,
          "ingredient": {
            "id": 170,
            "ingredient_code": 9060,
            "en_name": "HEPARIN SODIUM",
            "fr_name": "Héparine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02303108",
      "brand_name": "HEPARIN SODIUM INJECTION USP    (MULTIDOSE VIAL-WITH PRESERVATIVE)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104596002"
    },
    "created_date": "2020-08-26T15:07:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02303108",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "B01AB",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2020-09-11T00:00:00-04:00",
    "actual_start_date": "2020-08-21T00:00:00-04:00",
    "actual_end_date": "2020-09-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-09-08T12:25:31-04:00",
    "status": "resolved",
    "en_drug_brand_name": "HEPARIN SODIUM INJECTION USP       (MULTIDOSE VIAL-WITH PRESERVATIVE)",
    "en_drug_common_name": "HEPARIN SODIUM INJ USP (MULTIDOSE VIAL-WITH PRESERVATIVE)",
    "fr_drug_brand_name": "HEPARIN SODIUM INJ USP (MULTIDOSE VIAL-WITH PRESERVATIVE)",
    "fr_drug_common_name": "HEPARIN SODIUM INJ USP (MULTIDOSE VIAL-WITH PRESERVATIVE)",
    "en_ingredients": "HEPARIN SODIUM",
    "fr_ingredients": "Héparine sodique",
    "drug_strength": "10000UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intraveineuse\r\nSous-cutanée\r\nIntraveineuse\r\nSous-cutanée",
    "drug_package_quantity": "10 000U/ML 5ML 10LIVI CA",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122973,
    "drug": {
      "current_status": "MARKETED",
      "id": 57791,
      "drug_code": 95720,
      "updated_date": "2025-05-15T02:36:07-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8262777,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02468727",
      "brand_name": "SANDOZ PRAVASTATIN TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563003"
    },
    "created_date": "2020-08-26T15:09:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02468727",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2021-02-26T00:00:00-05:00",
    "actual_start_date": "2020-08-21T00:00:00-04:00",
    "actual_end_date": "2021-02-26T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-03-02T17:03:28-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ PRAVASTATIN TABLETS",
    "en_drug_common_name": "SANDOZ PRAVASTATIN TABLETS",
    "fr_drug_brand_name": "SANDOZ PRAVASTATIN TABLETS",
    "fr_drug_common_name": "SANDOZ PRAVASTATIN TABLETS",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100TAB BO V2 CA",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122976,
    "drug": {
      "current_status": "MARKETED",
      "id": 25110,
      "drug_code": 87623,
      "updated_date": "2025-05-15T02:33:39-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8259099,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02390833",
      "brand_name": "SANDOZ PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121003"
    },
    "created_date": "2020-08-26T15:11:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02390833",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2020-10-23T00:00:00-04:00",
    "actual_start_date": "2020-08-21T00:00:00-04:00",
    "actual_end_date": "2020-10-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-10-19T12:09:00-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ PREGABALIN",
    "en_drug_common_name": "SANDOZ PREGABALIN",
    "fr_drug_brand_name": "SANDOZ PREGABALIN",
    "fr_drug_common_name": "SANDOZ PREGABALIN",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "75MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500HGC BO CA",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122991,
    "drug": {
      "current_status": "MARKETED",
      "id": 10852,
      "drug_code": 66740,
      "updated_date": "2025-05-15T02:31:13-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254097,
          "ingredient": {
            "id": 526,
            "ingredient_code": 10128,
            "en_name": "AZATHIOPRINE",
            "fr_name": "Azathioprine (Azathioprine sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242907",
      "brand_name": "APO-AZATHIOPRINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101830001"
    },
    "created_date": "2020-08-26T17:20:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242907",
    "company_name": "APOTEX INC",
    "atc_number": "L04AX",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "estimated_end_date": "2020-10-30T00:00:00-04:00",
    "actual_start_date": "2020-08-24T00:00:00-04:00",
    "actual_end_date": "2020-09-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-14T13:12:46-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-AZATHIOPRINE",
    "en_drug_common_name": "AZATHIOPRINE",
    "fr_drug_brand_name": "APO-AZATHIOPRINE",
    "fr_drug_common_name": "AZATHIOPRINE",
    "en_ingredients": "AZATHIOPRINE",
    "fr_ingredients": "Azathioprine",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122994,
    "drug": {
      "current_status": "MARKETED",
      "id": 31560,
      "drug_code": 93876,
      "updated_date": "2025-05-15T02:35:17-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261801,
          "ingredient": {
            "id": 610,
            "ingredient_code": 1249,
            "en_name": "FELODIPINE",
            "fr_name": "Félodipine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452375",
      "brand_name": "APO-FELODIPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121733002"
    },
    "created_date": "2020-08-26T17:22:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452375",
    "company_name": "APOTEX INC",
    "atc_number": "C08CA",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.",
    "estimated_end_date": "2020-09-01T00:00:00-04:00",
    "actual_start_date": "2020-08-24T00:00:00-04:00",
    "actual_end_date": "2020-09-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-02T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-FELODIPINE",
    "en_drug_common_name": "FELODIPINE",
    "fr_drug_brand_name": "APO-FELODIPINE",
    "fr_drug_common_name": "FELODIPINE",
    "en_ingredients": "FELODIPINE",
    "fr_ingredients": "Félodipine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 122997,
    "drug": {
      "current_status": "MARKETED",
      "id": 13776,
      "drug_code": 73650,
      "updated_date": "2025-05-15T02:31:36-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254959,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02251582",
      "brand_name": "APO-RAMIPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122858002"
    },
    "created_date": "2020-08-26T17:26:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02251582",
    "company_name": "APOTEX INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2020-11-27T00:00:00-05:00",
    "actual_start_date": "2020-08-24T00:00:00-04:00",
    "actual_end_date": "2020-11-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-09T14:10:14-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-RAMIPRIL",
    "en_drug_common_name": "RAMIPRIL",
    "fr_drug_brand_name": "APO-RAMIPRIL",
    "fr_drug_common_name": "RAMILPRIL",
    "en_ingredients": "RAMIPRIL",
    "fr_ingredients": "Ramipril",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123027,
    "drug": {
      "current_status": "MARKETED",
      "id": 3136,
      "drug_code": 18012,
      "updated_date": "2025-12-03T00:30:33-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8252239,
          "ingredient": {
            "id": 164,
            "ingredient_code": 10225,
            "en_name": "LIDOCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "01901982",
      "brand_name": "LIDOCAINE HYDROCHLORIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80224",
      "number_of_ais": "1",
      "ai_group_no": "0101280001"
    },
    "created_date": "2020-08-26T19:59:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01901982",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "actual_start_date": "2020-08-26T00:00:00-04:00",
    "actual_end_date": "2021-03-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-03-29T14:30:50-04:00",
    "status": "resolved",
    "en_comments": "Item has been discontinued.",
    "fr_comments": "L'item est discontinué.",
    "en_drug_brand_name": "LIDOCAINE HYDROCHLORIDE INJECTION USP",
    "en_drug_common_name": "Lidocaine Hydrochloride Injection USP",
    "fr_drug_brand_name": "Chlorhydrate De Lidocaïne Injectable USP",
    "fr_drug_common_name": "Chlorhydrate De Lidocaïne Injectable USP",
    "en_ingredients": "LIDOCAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de lidocaïne",
    "drug_strength": "20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION\r\nBLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration\r\nBloc/Infiltration",
    "drug_package_quantity": "25 x 2mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123045,
    "drug": {
      "current_status": "MARKETED",
      "id": 10162,
      "drug_code": 64989,
      "updated_date": "2025-05-15T02:31:08-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253851,
          "ingredient": {
            "id": 2754,
            "ingredient_code": 1747,
            "en_name": "IFOSFAMIDE",
            "fr_name": "Ifosfamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        }
      ],
      "din": "02241357",
      "brand_name": "IFEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0120706002"
    },
    "created_date": "2020-08-27T15:12:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241357",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "L01AA",
    "atc_description": "ALKYLATINGAGENTS",
    "anticipated_start_date": "2020-08-27T00:00:00-04:00",
    "estimated_end_date": "2020-09-01T00:00:00-04:00",
    "actual_start_date": "2020-08-27T00:00:00-04:00",
    "actual_end_date": "2020-09-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-09-02T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "IFEX",
    "en_drug_common_name": "Ifosfamide for Injection, USP",
    "fr_drug_brand_name": "IFEX",
    "fr_drug_common_name": "Ifosfamide pour injection",
    "en_ingredients": "IFOSFAMIDE",
    "fr_ingredients": "Ifosfamide",
    "drug_strength": "1G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1g vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123056,
    "drug": {
      "current_status": "APPROVED",
      "id": 59133,
      "drug_code": 81418,
      "updated_date": "2025-05-15T06:04:53-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8360779,
          "ingredient": {
            "id": 15265,
            "ingredient_code": 12697,
            "en_name": "IBRITUMOMAB TIUXETAN",
            "fr_name": "IBRITUMOMAB TIUXÉTAN"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "2",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02328674",
      "brand_name": "ZEVALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152603001"
    },
    "created_date": "2020-08-27T18:08:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02328674",
    "company_name": "SERVIER CANADA INC",
    "atc_number": "V10XX",
    "anticipated_start_date": "2020-12-01T00:00:00-05:00",
    "actual_start_date": "2020-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-09-21T19:27:49-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "ZEVALIN",
    "en_drug_common_name": "ZEVALIN",
    "fr_drug_brand_name": "Zevalin",
    "fr_drug_common_name": "Zevalin",
    "en_ingredients": "IBRITUMOMAB TIUXETAN",
    "fr_ingredients": "IBRITUMOMAB TIUXETAN",
    "drug_strength": "3.2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "Kit for preparation of 90Y-Ibritumomab Tiuxetan",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123078,
    "drug": {
      "current_status": "MARKETED",
      "id": 18910,
      "drug_code": 80164,
      "updated_date": "2025-05-15T02:32:14-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256604,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02316110",
      "brand_name": "ACT QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858003"
    },
    "created_date": "2020-08-27T18:37:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02316110",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2020-09-30T00:00:00-04:00",
    "actual_start_date": "2020-08-26T00:00:00-04:00",
    "actual_end_date": "2020-09-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-17T20:51:53-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT QUETIAPINE",
    "en_drug_common_name": "QUETIAPINE 200MG FC TAB",
    "fr_drug_brand_name": "ACT-QUETIAPINE 200MG FC TAB",
    "fr_drug_common_name": "QUETIAPINE 200MG FC TAB",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123081,
    "drug": {
      "current_status": "MARKETED",
      "id": 18964,
      "drug_code": 80234,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256632,
          "ingredient": {
            "id": 2442,
            "ingredient_code": 11516,
            "en_name": "ROPINIROLE",
            "fr_name": "Ropinirole (Chlorhydrate de ropinirole)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02316846",
      "brand_name": "TEVA-ROPINIROLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132618001"
    },
    "created_date": "2020-08-27T18:38:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02316846",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N04BC",
    "atc_description": "DOPAMINERGIC AGENTS",
    "estimated_end_date": "2020-11-30T00:00:00-05:00",
    "actual_start_date": "2020-08-26T00:00:00-04:00",
    "actual_end_date": "2020-11-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-12T18:36:37-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ROPINIROLE",
    "en_drug_common_name": "ROPINIROLE 0.25MG FC TAB",
    "fr_drug_brand_name": "ACT-ROPINIROLE 0.25MG FC TAB",
    "fr_drug_common_name": "ROPINIROLE 0.25MG FC TAB",
    "en_ingredients": "ROPINIROLE",
    "fr_ingredients": "ROPINIROLE",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123084,
    "drug": {
      "current_status": "MARKETED",
      "id": 1598,
      "drug_code": 13439,
      "updated_date": "2025-05-15T02:30:53-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251767,
          "ingredient": {
            "id": 886,
            "ingredient_code": 7558,
            "en_name": "CLOBETASOL PROPIONATE",
            "fr_name": "Propionate de clobétasol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01910280",
      "brand_name": "TEVA-CLOBETASOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74826",
      "number_of_ais": "1",
      "ai_group_no": "0110995001"
    },
    "created_date": "2020-08-27T18:40:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01910280",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "D07AD",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2020-10-31T00:00:00-04:00",
    "actual_start_date": "2020-08-26T00:00:00-04:00",
    "actual_end_date": "2020-09-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-25T13:45:43-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CLOBETASOL",
    "en_drug_common_name": "CLOBETASOL 0.05% OINTMENT",
    "fr_drug_brand_name": "TEVA-CLOBETASOL 0.05% OINTMENT",
    "fr_drug_common_name": "CLOBETASOL 0.05% OINTMENT",
    "en_ingredients": "CLOBETASOL PROPIONATE",
    "fr_ingredients": "Propionate de clobétasol",
    "drug_strength": "0.05%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "450g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123087,
    "drug": {
      "current_status": "MARKETED",
      "id": 5900,
      "drug_code": 4129,
      "updated_date": "2025-05-15T02:30:30-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250596,
          "ingredient": {
            "id": 910,
            "ingredient_code": 10126,
            "en_name": "INDOMETHACIN",
            "fr_name": "Indométhacine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00337420",
      "brand_name": "TEVA-INDOMETHACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "56714",
      "number_of_ais": "1",
      "ai_group_no": "0101832001"
    },
    "created_date": "2020-08-27T18:40:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00337420",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "M01AB",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2020-09-30T00:00:00-04:00",
    "actual_start_date": "2020-08-26T00:00:00-04:00",
    "actual_end_date": "2020-09-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-17T20:52:12-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-INDOMETHACIN",
    "en_drug_common_name": "INDOMETHACIN 25MG CAPS",
    "fr_drug_brand_name": "TEVA-INDOMETHACIN 25MG CAPS",
    "fr_drug_common_name": "INDOMETHACIN 25MG CAPS",
    "en_ingredients": "INDOMETHACIN",
    "fr_ingredients": "Indométhacine",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123090,
    "drug": {
      "current_status": "MARKETED",
      "id": 17050,
      "drug_code": 78072,
      "updated_date": "2025-05-15T02:31:56-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256015,
          "ingredient": {
            "id": 1598,
            "ingredient_code": 1250,
            "en_name": "OMEPRAZOLE",
            "fr_name": "Oméprazole (Oméprazole magnésium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02295415",
      "brand_name": "TEVA-OMEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121643001"
    },
    "created_date": "2020-08-27T18:41:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02295415",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2020-12-31T00:00:00-05:00",
    "actual_start_date": "2020-08-26T00:00:00-04:00",
    "actual_end_date": "2020-11-25T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-26T21:13:25-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-OMEPRAZOLE",
    "en_drug_common_name": "OMEPRAZOLE 20MG TAB",
    "fr_drug_brand_name": "TEVA-OMEPRAZOLE 20MG TAB",
    "fr_drug_common_name": "OMEPRAZOLE 20MG TAB",
    "en_ingredients": "OMEPRAZOLE",
    "fr_ingredients": "Oméprazole",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123093,
    "drug": {
      "current_status": "MARKETED",
      "id": 25626,
      "drug_code": 88039,
      "updated_date": "2025-05-15T02:33:42-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259255,
          "ingredient": {
            "id": 2740,
            "ingredient_code": 11923,
            "en_name": "TEMOZOLOMIDE",
            "fr_name": "Témozolomide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02395282",
      "brand_name": "TEVA-TEMOZOLOMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138781003"
    },
    "created_date": "2020-08-27T18:43:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02395282",
    "company_name": "ACTAVIS PHARMA COMPANY",
    "atc_number": "L01AX",
    "atc_description": "ALKYLATINGAGENTS",
    "estimated_end_date": "2020-09-30T00:00:00-04:00",
    "actual_start_date": "2020-08-26T00:00:00-04:00",
    "actual_end_date": "2020-09-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-10T19:49:27-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT TEMOZOLOMIDE",
    "en_drug_common_name": "TEMOZOLOMIDE 100MG CAP",
    "fr_drug_brand_name": "ACT-TEMOZOLOMIDE 100MG CAP",
    "fr_drug_common_name": "TEMOZOLOMIDE 100MG CAP",
    "en_ingredients": "TEMOZOLOMIDE",
    "fr_ingredients": "Témozolomide",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "5",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123123,
    "drug": {
      "current_status": "MARKETED",
      "id": 2312,
      "drug_code": 15211,
      "updated_date": "2025-12-03T00:30:32-05:00",
      "company": {
        "id": 1700,
        "created_date": "2017-03-09T13:25:18-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17140,
        "mfr_code": "",
        "name": "ENDO OPERATIONS LTD.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD",
        "province": "DUBLIN",
        "country": "IRELAND",
        "city": "BALLSBRIDGE",
        "postal_code": "D04 H9P8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252022,
          "ingredient": {
            "id": 1126,
            "ingredient_code": 8298,
            "en_name": "DEXTROAMPHETAMINE SULFATE",
            "fr_name": "Sulfate de dextroamphétamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01924559",
      "brand_name": "DEXEDRINE SPANSULE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76892",
      "number_of_ais": "1",
      "ai_group_no": "0105933003"
    },
    "created_date": "2020-08-27T21:08:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01924559",
    "company_name": "PALADIN LABS INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2020-08-27T00:00:00-04:00",
    "estimated_end_date": "2020-11-01T00:00:00-04:00",
    "actual_end_date": "2020-10-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-29T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DEXEDRINE SPANSULE SRC 10MG",
    "en_drug_common_name": "DEXTROAMPHETAMINE SULFATE",
    "fr_drug_brand_name": "DEXEDRINE SPANSULE SRC 10MG",
    "fr_drug_common_name": "Sulfate de dextroamphétamine",
    "en_ingredients": "DEXTROAMPHETAMINE SULFATE",
    "fr_ingredients": "Sulfate de dextroamphétamine",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE (SUSTAINED-RELEASE)",
    "drug_dosage_form_fr": "Capsule (à action soutenue)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 caps",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123133,
    "drug": {
      "current_status": "MARKETED",
      "id": 23036,
      "drug_code": 85625,
      "updated_date": "2025-05-15T02:33:02-04:00",
      "company": {
        "id": 192,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 3617,
        "mfr_code": "BOE07",
        "name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "5180 SOUTH SERVICE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BURLINGTON",
        "postal_code": "L7L 5H4",
        "post_office_box": "",
        "contact_information": "1800 263 2425"
      },
      "drug_ingredients": [
        {
          "id": 8258333,
          "ingredient": {
            "id": 2730,
            "ingredient_code": 11907,
            "en_name": "TELMISARTAN",
            "fr_name": "Telmisartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8258332,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02371057",
      "brand_name": "TWYNSTA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252947004"
    },
    "created_date": "2020-08-28T11:24:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02371057",
    "company_name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
    "atc_number": "C09DB",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "anticipated_start_date": "2020-08-31T00:00:00-04:00",
    "estimated_end_date": "2020-09-28T00:00:00-04:00",
    "actual_start_date": "2020-09-11T00:00:00-04:00",
    "actual_end_date": "2020-09-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-09-19T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TWYNSTA",
    "en_drug_common_name": "Twynsta",
    "fr_drug_brand_name": "Twynsta",
    "fr_drug_common_name": "Twynsta 80+10MG",
    "en_ingredients": "TELMISARTAN\r\nAMLODIPINE",
    "fr_ingredients": "Telmisartan",
    "drug_strength": "80MG\r\n10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "28's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123146,
    "drug": {
      "current_status": "MARKETED",
      "id": 20282,
      "drug_code": 81732,
      "updated_date": "2025-05-15T02:32:31-04:00",
      "company": {
        "id": 1080,
        "created_date": "2017-03-09T13:23:42-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 3652,
        "mfr_code": "",
        "name": "DENTSPLY CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "1",
        "street_name": "525 ROWNTREE DAIRY ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 7K6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257189,
          "ingredient": {
            "id": 664,
            "ingredient_code": 8926,
            "en_name": "EPINEPHRINE",
            "fr_name": "Épinéphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.01",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8257188,
          "ingredient": {
            "id": 164,
            "ingredient_code": 10225,
            "en_name": "LIDOCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02331640",
      "brand_name": "XYLOCAINE DENTAL LIDOCAINE HCL 2% AND EPINEPHRINE 1:100,000",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0201284005"
    },
    "created_date": "2020-08-28T13:50:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02331640",
    "company_name": "DENTSPLY CANADA LIMITED",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2020-08-28T00:00:00-04:00",
    "estimated_end_date": "2020-10-31T00:00:00-04:00",
    "actual_start_date": "2020-08-28T00:00:00-04:00",
    "actual_end_date": "2020-09-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-09-25T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "XYLOCAINE DENTAL LIDOCAINE HCL 2% AND EPINEPHRINE 1:100,000",
    "en_drug_common_name": "EPINEPHRINE/ LIDOCAINE HYDROCHLORIDE",
    "fr_drug_brand_name": "XYLOCAINE DENTAL LIDOCAINE HCL 2% AND EPINEPHRINE 1:100,000",
    "fr_drug_common_name": "EPINEPHRINE/ LIDOCAINE HYDROCHLORIDE",
    "en_ingredients": "LIDOCAINE HYDROCHLORIDE\r\nEPINEPHRINE",
    "fr_ingredients": "Chlorhydrate de lidocaïne\r\nÉpinéphrine",
    "drug_strength": "20.00MG\r\n0.01MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION\r\nBLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration\r\nBloc/Infiltration",
    "drug_package_quantity": "50 x 1.8 mL Cartridges",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123149,
    "drug": {
      "current_status": "MARKETED",
      "id": 27382,
      "drug_code": 89622,
      "updated_date": "2025-12-03T00:32:21-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259904,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02411628",
      "brand_name": "ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963004"
    },
    "created_date": "2020-08-28T13:57:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02411628",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2021-02-15T00:00:00-05:00",
    "estimated_end_date": "2021-02-16T00:00:00-05:00",
    "actual_start_date": "2021-02-15T00:00:00-05:00",
    "actual_end_date": "2021-02-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-02-17T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123152,
    "drug": {
      "current_status": "MARKETED",
      "id": 27382,
      "drug_code": 89622,
      "updated_date": "2025-12-03T00:32:21-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259904,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02411628",
      "brand_name": "ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963004"
    },
    "created_date": "2020-08-28T14:00:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02411628",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2021-02-15T00:00:00-05:00",
    "estimated_end_date": "2021-02-16T00:00:00-05:00",
    "actual_start_date": "2021-02-15T00:00:00-05:00",
    "actual_end_date": "2021-02-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-02-17T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123155,
    "drug": {
      "current_status": "MARKETED",
      "id": 27382,
      "drug_code": 89622,
      "updated_date": "2025-12-03T00:32:21-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259904,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02411628",
      "brand_name": "ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963004"
    },
    "created_date": "2020-08-28T15:02:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02411628",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2021-02-15T00:00:00-05:00",
    "estimated_end_date": "2021-02-16T00:00:00-05:00",
    "actual_start_date": "2021-02-15T00:00:00-05:00",
    "actual_end_date": "2021-02-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-02-17T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123172,
    "drug": {
      "current_status": "MARKETED",
      "id": 10902,
      "drug_code": 66824,
      "updated_date": "2025-05-15T02:31:13-04:00",
      "company": {
        "id": 598,
        "created_date": "2017-03-09T13:22:57-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 11314,
        "mfr_code": "TPT08",
        "name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254108,
          "ingredient": {
            "id": 2848,
            "ingredient_code": 7509,
            "en_name": "HYDROCORTISONE VALERATE",
            "fr_name": "Valérate d'hydrocortisone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242984",
      "brand_name": "HYDROVAL CREAM 0.2%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0112513001"
    },
    "created_date": "2020-08-28T21:57:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242984",
    "company_name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
    "atc_number": "D07AA",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2020-11-13T00:00:00-05:00",
    "actual_start_date": "2020-08-24T00:00:00-04:00",
    "actual_end_date": "2020-11-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-12-03T17:50:53-05:00",
    "status": "resolved",
    "en_drug_brand_name": "HYDROVAL CREAM 0.2%",
    "en_drug_common_name": "HYDROVAL CREAM 0.2%",
    "fr_drug_brand_name": "HYDROVAL CREAM 0.2%",
    "fr_drug_common_name": "HYDROVAL CREAM 0.2%",
    "en_ingredients": "HYDROCORTISONE VALERATE",
    "fr_ingredients": "Valérate d'hydrocortisone",
    "drug_strength": "0.2%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "15",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123175,
    "drug": {
      "current_status": "MARKETED",
      "id": 30708,
      "drug_code": 9276,
      "updated_date": "2025-05-15T02:30:44-04:00",
      "company": {
        "id": 598,
        "created_date": "2017-03-09T13:22:57-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 11314,
        "mfr_code": "TPT08",
        "name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251141,
          "ingredient": {
            "id": 478,
            "ingredient_code": 7579,
            "en_name": "FLUOCINONIDE",
            "fr_name": "Fluocinonide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "00716863",
      "brand_name": "LYDERM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68229",
      "number_of_ais": "1",
      "ai_group_no": "0106313001"
    },
    "created_date": "2020-08-28T21:59:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00716863",
    "company_name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2020-10-10T00:00:00-04:00",
    "actual_start_date": "2020-08-24T00:00:00-04:00",
    "actual_end_date": "2020-10-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-08T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LYDERM CREAM 0.05%",
    "en_drug_common_name": "LYDERM CREAM 0.05%",
    "fr_drug_brand_name": "LYDERM CREAM 0.05%",
    "fr_drug_common_name": "LYDERM CREAM 0.05%",
    "en_ingredients": "FLUOCINONIDE",
    "fr_ingredients": "Fluocinonide",
    "drug_strength": "0.05%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123190,
    "drug": {
      "current_status": "MARKETED",
      "id": 30708,
      "drug_code": 9276,
      "updated_date": "2025-05-15T02:30:44-04:00",
      "company": {
        "id": 598,
        "created_date": "2017-03-09T13:22:57-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 11314,
        "mfr_code": "TPT08",
        "name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251141,
          "ingredient": {
            "id": 478,
            "ingredient_code": 7579,
            "en_name": "FLUOCINONIDE",
            "fr_name": "Fluocinonide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "00716863",
      "brand_name": "LYDERM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68229",
      "number_of_ais": "1",
      "ai_group_no": "0106313001"
    },
    "created_date": "2020-08-28T22:24:30-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00716863",
    "company_name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "discontinuation_date": "2020-08-17T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2020-08-28T22:24:58-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "LYDERM CREAM 0.05%",
    "en_drug_common_name": "LYDERM CREAM 0.05%",
    "fr_drug_brand_name": "LYDERM CREAM 0.05%",
    "fr_drug_common_name": "LYDERM CREAM 0.05%",
    "en_ingredients": "FLUOCINONIDE",
    "fr_ingredients": "Fluocinonide",
    "drug_strength": "0.05%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "15",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123195,
    "drug": {
      "current_status": "MARKETED",
      "id": 65363,
      "drug_code": 94404,
      "updated_date": "2025-05-15T02:35:34-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262079,
          "ingredient": {
            "id": 500,
            "ingredient_code": 6850,
            "en_name": "BENZOYL PEROXIDE",
            "fr_name": "Peroxyde de benzoyle"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        },
        {
          "id": 8262078,
          "ingredient": {
            "id": 1632,
            "ingredient_code": 224,
            "en_name": "ADAPALENE",
            "fr_name": "Adapalène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02456923",
      "brand_name": "TARO-ADAPALENE/BENZOYL PEROXIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252888001"
    },
    "created_date": "2020-08-28T23:16:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02456923",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D10AD",
    "atc_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
    "estimated_end_date": "2021-03-05T00:00:00-05:00",
    "actual_start_date": "2020-08-01T00:00:00-04:00",
    "actual_end_date": "2021-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-05-02T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-ADAPALENE/BENZOYL PEROXIDE",
    "en_drug_common_name": "ADAPALENE/BENZOYL PEROXIDE",
    "fr_drug_brand_name": "TARO-ADAPALENE/BENZOYL PEROXIDE",
    "fr_drug_common_name": "ADAPALENE/BENZOYL PEROXIDE",
    "en_ingredients": "ADAPALENE\r\nBENZOYL PEROXIDE",
    "fr_ingredients": "Adapalène\r\nPeroxyde de benzoyle",
    "drug_strength": "0.1%\r\n2.5%",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "70",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123219,
    "drug": {
      "current_status": "MARKETED",
      "id": 27502,
      "drug_code": 8974,
      "updated_date": "2025-05-15T02:30:42-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251117,
          "ingredient": {
            "id": 186,
            "ingredient_code": 9152,
            "en_name": "DOCUSATE SODIUM",
            "fr_name": "Docusate sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00716731",
      "brand_name": "TARO-DOCUSATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "67694",
      "number_of_ais": "1",
      "ai_group_no": "0104351002"
    },
    "created_date": "2020-08-28T23:47:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00716731",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "A06AA",
    "atc_description": "DRUGS FOR CONSTIPATION",
    "estimated_end_date": "2020-10-23T00:00:00-04:00",
    "actual_start_date": "2020-08-15T00:00:00-04:00",
    "actual_end_date": "2020-10-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-27T18:13:25-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-DOCUSATE",
    "en_drug_common_name": "DOCUSATE",
    "fr_drug_brand_name": "TARO-DOCUSATE",
    "fr_drug_common_name": "DOCUSATE",
    "en_ingredients": "DOCUSATE SODIUM",
    "fr_ingredients": "Docusate sodique",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123222,
    "drug": {
      "current_status": "MARKETED",
      "id": 30720,
      "drug_code": 9277,
      "updated_date": "2025-05-15T02:30:44-04:00",
      "company": {
        "id": 598,
        "created_date": "2017-03-09T13:22:57-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 11314,
        "mfr_code": "TPT08",
        "name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251142,
          "ingredient": {
            "id": 136,
            "ingredient_code": 8508,
            "en_name": "NYSTATIN",
            "fr_name": "Nystatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        }
      ],
      "din": "00716901",
      "brand_name": "NYADERM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68230",
      "number_of_ais": "1",
      "ai_group_no": "0105858004"
    },
    "created_date": "2020-08-28T23:49:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00716901",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "G01AA",
    "atc_description": "ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.",
    "estimated_end_date": "2021-03-19T00:00:00-04:00",
    "actual_start_date": "2020-08-15T00:00:00-04:00",
    "actual_end_date": "2021-03-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-05-01T23:06:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "NYADERM VAG CRM 25000UNIT/GM",
    "en_drug_common_name": "NYADERM VAG CRM 25000UNIT/GM",
    "fr_drug_brand_name": "NYADERM VAG CRM 25000UNIT/GM",
    "fr_drug_common_name": "NYADERM VAG CRM 25000UNIT/GM",
    "en_ingredients": "NYSTATIN",
    "fr_ingredients": "Nystatine",
    "drug_strength": "25000UNIT",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "VAGINAL\r\nVAGINAL",
    "drug_route_fr": "Vaginale\r\nVaginale",
    "drug_package_quantity": "120",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123231,
    "drug": {
      "current_status": "MARKETED",
      "id": 31938,
      "drug_code": 9448,
      "updated_date": "2025-05-15T02:30:44-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251168,
          "ingredient": {
            "id": 54,
            "ingredient_code": 8523,
            "en_name": "GRAMICIDIN",
            "fr_name": "Gramicidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        },
        {
          "id": 8251167,
          "ingredient": {
            "id": 56,
            "ingredient_code": 8638,
            "en_name": "NEOMYCIN",
            "fr_name": "Néomycine (Sulfate de néomycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": true
        },
        {
          "id": 8251166,
          "ingredient": {
            "id": 136,
            "ingredient_code": 8508,
            "en_name": "NYSTATIN",
            "fr_name": "Nystatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        },
        {
          "id": 8251165,
          "ingredient": {
            "id": 502,
            "ingredient_code": 7588,
            "en_name": "TRIAMCINOLONE ACETONIDE",
            "fr_name": "Acétonide  de triamcinolone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        }
      ],
      "din": "00717002",
      "brand_name": "VIADERM KC CRM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68586",
      "number_of_ais": "4",
      "ai_group_no": "0405625002"
    },
    "created_date": "2020-08-28T23:59:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00717002",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D07CB",
    "atc_description": "CORTICOSTEROIDS, COMB WITH ANTIBIOTICS",
    "estimated_end_date": "2020-11-06T00:00:00-05:00",
    "actual_start_date": "2020-08-15T00:00:00-04:00",
    "actual_end_date": "2020-11-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-06T18:41:31-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VIADERM KC CRM",
    "en_drug_common_name": "VIADERM KC CRM",
    "fr_drug_brand_name": "VIADERM KC CRM",
    "fr_drug_common_name": "VIADERM KC CRM",
    "en_ingredients": "TRIAMCINOLONE ACETONIDE\r\nNEOMYCIN\r\nGRAMICIDIN\r\nNYSTATIN",
    "fr_ingredients": "Acétonide  de triamcinolone\r\nNéomycine\r\nGramicidine\r\nNystatine",
    "drug_strength": "1MG\r\n2.5MG\r\n0.25MG\r\n100000UNIT",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "15",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123234,
    "drug": {
      "current_status": "MARKETED",
      "id": 31938,
      "drug_code": 9448,
      "updated_date": "2025-05-15T02:30:44-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251168,
          "ingredient": {
            "id": 54,
            "ingredient_code": 8523,
            "en_name": "GRAMICIDIN",
            "fr_name": "Gramicidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        },
        {
          "id": 8251167,
          "ingredient": {
            "id": 56,
            "ingredient_code": 8638,
            "en_name": "NEOMYCIN",
            "fr_name": "Néomycine (Sulfate de néomycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": true
        },
        {
          "id": 8251166,
          "ingredient": {
            "id": 136,
            "ingredient_code": 8508,
            "en_name": "NYSTATIN",
            "fr_name": "Nystatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        },
        {
          "id": 8251165,
          "ingredient": {
            "id": 502,
            "ingredient_code": 7588,
            "en_name": "TRIAMCINOLONE ACETONIDE",
            "fr_name": "Acétonide  de triamcinolone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        }
      ],
      "din": "00717002",
      "brand_name": "VIADERM KC CRM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68586",
      "number_of_ais": "4",
      "ai_group_no": "0405625002"
    },
    "created_date": "2020-08-29T00:01:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00717002",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D07CB",
    "atc_description": "CORTICOSTEROIDS, COMB WITH ANTIBIOTICS",
    "actual_start_date": "2020-08-15T00:00:00-04:00",
    "actual_end_date": "2020-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-03T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VIADERM KC CRM",
    "en_drug_common_name": "VIADERM KC CRM",
    "fr_drug_brand_name": "VIADERM KC CRM",
    "fr_drug_common_name": "VIADERM KC CRM",
    "en_ingredients": "TRIAMCINOLONE ACETONIDE\r\nNEOMYCIN\r\nGRAMICIDIN\r\nNYSTATIN",
    "fr_ingredients": "Acétonide  de triamcinolone\r\nNéomycine\r\nGramicidine\r\nNystatine",
    "drug_strength": "1MG\r\n2.5MG\r\n0.25MG\r\n100000UNIT",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "454",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123252,
    "drug": {
      "current_status": "MARKETED",
      "id": 30756,
      "drug_code": 92817,
      "updated_date": "2025-05-15T02:34:58-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261325,
          "ingredient": {
            "id": 2740,
            "ingredient_code": 11923,
            "en_name": "TEMOZOLOMIDE",
            "fr_name": "Témozolomide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02443473",
      "brand_name": "TARO-TEMOZOLOMIDE",
      "brand_name_fr": "TARO-TÉMOZOLOMIDE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138781001"
    },
    "created_date": "2020-08-29T00:23:53-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02443473",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "L01AX",
    "atc_description": "ALKYLATINGAGENTS",
    "discontinuation_date": "2020-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2020-08-29T00:24:22-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TARO-TEMOZOLOMIDE",
    "en_drug_common_name": "TEMOZOLOMIDE",
    "fr_drug_brand_name": "TARO-TEMOZOLOMIDE",
    "fr_drug_common_name": "TEMOZOLOMIDE",
    "en_ingredients": "TEMOZOLOMIDE",
    "fr_ingredients": "Témozolomide",
    "drug_strength": "5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "20",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123255,
    "drug": {
      "current_status": "MARKETED",
      "id": 30758,
      "drug_code": 92818,
      "updated_date": "2025-05-15T02:34:58-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261326,
          "ingredient": {
            "id": 2740,
            "ingredient_code": 11923,
            "en_name": "TEMOZOLOMIDE",
            "fr_name": "Témozolomide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02443481",
      "brand_name": "TARO-TEMOZOLOMIDE",
      "brand_name_fr": "TARO-TÉMOZOLOMIDE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138781002"
    },
    "created_date": "2020-08-29T00:25:46-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02443481",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "L01AX",
    "atc_description": "ALKYLATINGAGENTS",
    "discontinuation_date": "2020-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2020-08-29T00:26:15-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TARO-TEMOZOLOMIDE",
    "en_drug_common_name": "TEMOZOLOMIDE",
    "fr_drug_brand_name": "TARO-TEMOZOLOMIDE",
    "fr_drug_common_name": "TEMOZOLOMIDE",
    "en_ingredients": "TEMOZOLOMIDE",
    "fr_ingredients": "Témozolomide",
    "drug_strength": "20MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "20",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123258,
    "drug": {
      "current_status": "MARKETED",
      "id": 30760,
      "drug_code": 92820,
      "updated_date": "2025-05-15T02:34:58-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261327,
          "ingredient": {
            "id": 2740,
            "ingredient_code": 11923,
            "en_name": "TEMOZOLOMIDE",
            "fr_name": "Témozolomide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02443511",
      "brand_name": "TARO-TEMOZOLOMIDE",
      "brand_name_fr": "TARO-TÉMOZOLOMIDE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138781003"
    },
    "created_date": "2020-08-29T00:27:36-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02443511",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "L01AX",
    "atc_description": "ALKYLATINGAGENTS",
    "discontinuation_date": "2020-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2020-08-29T00:28:15-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TARO-TEMOZOLOMIDE",
    "en_drug_common_name": "TEMOZOLOMIDE",
    "fr_drug_brand_name": "TARO-TEMOZOLOMIDE",
    "fr_drug_common_name": "TEMOZOLOMIDE",
    "en_ingredients": "TEMOZOLOMIDE",
    "fr_ingredients": "Témozolomide",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "20",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123386,
    "drug": {
      "current_status": "MARKETED",
      "id": 10566,
      "drug_code": 66078,
      "updated_date": "2025-05-15T02:31:10-04:00",
      "company": {
        "id": 430,
        "created_date": "2017-03-09T13:22:46-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15812,
        "mfr_code": "",
        "name": "CHEPLAPHARM ARZNEIMITTEL GMBH",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "ZIEGELHOF 24",
        "province": "MECKLENBURG - WEST POMERANIA",
        "country": "GERMANY",
        "city": "GREIFSWALD",
        "postal_code": "17489",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254010,
          "ingredient": {
            "id": 2796,
            "ingredient_code": 11996,
            "en_name": "VERTEPORFIN",
            "fr_name": "Vertéporfine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02242367",
      "brand_name": "VISUDYNE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0141121001"
    },
    "created_date": "2020-08-31T14:00:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242367",
    "company_name": "CHEPLAPHARM ARZNEIMITTEL GMBH",
    "atc_number": "S01LA",
    "atc_description": "OCULAR VASCULAR DISORDER AGENTS",
    "estimated_end_date": "2022-01-31T00:00:00-05:00",
    "actual_start_date": "2020-08-01T00:00:00-04:00",
    "actual_end_date": "2022-01-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-02-11T19:00:33-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VISUDYNE",
    "en_drug_common_name": "verteporfin",
    "fr_drug_brand_name": "VISUDYNE",
    "fr_drug_common_name": "verteporfine",
    "en_ingredients": "VERTEPORFIN",
    "fr_ingredients": "Vertéporfine",
    "drug_strength": "15MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "15ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123389,
    "drug": {
      "current_status": "MARKETED",
      "id": 19938,
      "drug_code": 81248,
      "updated_date": "2025-05-15T02:32:25-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256971,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02327163",
      "brand_name": "SANDOZ FENTANYL PATCH",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302012"
    },
    "created_date": "2020-08-31T14:40:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02327163",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N02AB",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2020-09-04T00:00:00-04:00",
    "actual_start_date": "2020-08-28T00:00:00-04:00",
    "actual_end_date": "2020-09-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-09-08T12:23:38-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ FENTANYL PATCH",
    "en_drug_common_name": "SANDOZ FENTANYL PATCH",
    "fr_drug_brand_name": "SANDOZ FENTANYL PATCH",
    "fr_drug_common_name": "SANDOZ FENTANYL PATCH",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "100MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "100 MCG/H 5TTSS CA",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123392,
    "drug": {
      "current_status": "MARKETED",
      "id": 20724,
      "drug_code": 82509,
      "updated_date": "2025-05-15T02:32:33-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257335,
          "ingredient": {
            "id": 862,
            "ingredient_code": 768,
            "en_name": "FINASTERIDE",
            "fr_name": "Finastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02339471",
      "brand_name": "SANDOZ FINASTERIDE A",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124110002"
    },
    "created_date": "2020-08-31T14:42:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02339471",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "D11AX",
    "atc_description": "OTHER DERMATOLOGICAL PREPARATIONS",
    "estimated_end_date": "2020-09-11T00:00:00-04:00",
    "actual_start_date": "2020-08-28T00:00:00-04:00",
    "actual_end_date": "2020-09-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-09-21T15:47:57-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ FINASTERIDE A",
    "en_drug_common_name": "SANDOZ FINASTERIDE A",
    "fr_drug_brand_name": "SANDOZ FINASTERIDE A",
    "fr_drug_common_name": "SANDOZ FINASTERIDE A",
    "en_ingredients": "FINASTERIDE",
    "fr_ingredients": "Finastéride",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 FCT BO CA",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123398,
    "drug": {
      "current_status": "MARKETED",
      "id": 18330,
      "drug_code": 79602,
      "updated_date": "2025-05-15T02:32:10-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256426,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02310384",
      "brand_name": "SANDOZ OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783002"
    },
    "created_date": "2020-08-31T14:45:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02310384",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2020-09-11T00:00:00-04:00",
    "actual_start_date": "2020-08-28T00:00:00-04:00",
    "actual_end_date": "2020-09-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-09-08T12:26:31-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ OLANZAPINE",
    "en_drug_common_name": "SANDOZ OLANZAPINE",
    "fr_drug_brand_name": "SANDOZ OLANZAPINE",
    "fr_drug_common_name": "SANDOZ OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "10.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 FCT BO CA",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123416,
    "drug": {
      "current_status": "MARKETED",
      "id": 19506,
      "drug_code": 80802,
      "updated_date": "2025-05-15T02:32:20-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256815,
          "ingredient": {
            "id": 862,
            "ingredient_code": 768,
            "en_name": "FINASTERIDE",
            "fr_name": "Finastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02322579",
      "brand_name": "SANDOZ FINASTERIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124110001"
    },
    "created_date": "2020-08-31T15:12:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02322579",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "G04CB",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "estimated_end_date": "2021-03-05T00:00:00-05:00",
    "actual_start_date": "2020-08-28T00:00:00-04:00",
    "actual_end_date": "2021-03-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2021-03-08T19:13:58-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ FINASTERIDE",
    "en_drug_common_name": "SANDOZ FINASTERIDE",
    "fr_drug_brand_name": "SANDOZ FINASTERIDE",
    "fr_drug_common_name": "SANDOZ FINASTERIDE",
    "en_ingredients": "FINASTERIDE",
    "fr_ingredients": "Finastéride",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 FCT UD CA",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123419,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 7148,
      "drug_code": 4857,
      "updated_date": "2025-05-15T03:27:56-04:00",
      "company": {
        "id": 110,
        "created_date": "2017-03-09T13:22:35-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 5096,
        "mfr_code": "SEV07",
        "name": "SERVIER CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "270",
        "street_name": "3224 AVENUE JEAN-BÉRAUD",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7T 2S4",
        "post_office_box": "",
        "contact_information": "Address: 3224, rue Jean-Béraud, bur. 270, Laval, Quebec, H7T 2S4\r\nPhone : (450) 978-9700"
      },
      "drug_ingredients": [
        {
          "id": 8277428,
          "ingredient": {
            "id": 1366,
            "ingredient_code": 1960,
            "en_name": "INDAPAMIDE",
            "fr_name": "Indapamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00564966",
      "brand_name": "LOZIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "58912",
      "number_of_ais": "1",
      "ai_group_no": "0115402001"
    },
    "created_date": "2020-08-31T15:13:55-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00564966",
    "company_name": "SERVIER CANADA INC",
    "atc_number": "C03BA",
    "atc_description": "LOW-CEILING DIURETICS, EXCL THIAZIDES",
    "discontinuation_date": "2020-08-31T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "This report cancels and replaces discontinuation report #120920 in order to update the 'actual discontinuation date'",
    "fr_discontinuation_comments": "Ce rapport annule et remplace le rapport de discontinuation # 120920 afin de mettre à jour la `` date d'arrêt réelle ''",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-09-01T05:00:18-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "LOZIDE",
    "en_drug_common_name": "Lozide",
    "fr_drug_brand_name": "lozide",
    "fr_drug_common_name": "lozide",
    "en_ingredients": "INDAPAMIDE",
    "fr_ingredients": "Indapamide",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123421,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 18682,
      "drug_code": 79952,
      "updated_date": "2025-05-15T04:13:58-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8345806,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02314002",
      "brand_name": "SANDOZ QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858002"
    },
    "created_date": "2020-08-31T15:14:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02314002",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "hc_updated_date": "2023-11-17T18:20:51-05:00",
    "actual_start_date": "2020-08-28T00:00:00-04:00",
    "actual_end_date": "2021-02-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-11-17T18:20:54-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ QUETIAPINE",
    "en_drug_common_name": "SANDOZ QUETIAPINE",
    "fr_drug_brand_name": "SANDOZ QUETIAPINE",
    "fr_drug_common_name": "SANDOZ QUETIAPINE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quetiapine",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 FCT BO V1 CA",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123435,
    "drug": {
      "current_status": "MARKETED",
      "id": 2682,
      "drug_code": 1649,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8250291,
          "ingredient": {
            "id": 572,
            "ingredient_code": 649,
            "en_name": "LIPASE",
            "fr_name": "Lipase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250290,
          "ingredient": {
            "id": 568,
            "ingredient_code": 253,
            "en_name": "AMYLASE",
            "fr_name": "Amylase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250289,
          "ingredient": {
            "id": 570,
            "ingredient_code": 648,
            "en_name": "PROTEASE",
            "fr_name": "Protéase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "35000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00263818",
      "brand_name": "COTAZYM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "42494",
      "number_of_ais": "3",
      "ai_group_no": "0302964032"
    },
    "created_date": "2020-08-31T19:04:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00263818",
    "company_name": "MERCK CANADA INC",
    "atc_number": "A09AA",
    "atc_description": "DIGESTIVES, INCL ENZYMES",
    "anticipated_start_date": "2020-10-09T00:00:00-04:00",
    "estimated_end_date": "2020-10-23T00:00:00-04:00",
    "actual_start_date": "2020-10-05T00:00:00-04:00",
    "actual_end_date": "2020-10-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-10-15T15:25:18-04:00",
    "status": "resolved",
    "en_drug_brand_name": "COTAZYM",
    "en_drug_common_name": "PANCRELIPASE CAPSULES",
    "fr_drug_brand_name": "COTAZYM",
    "fr_drug_common_name": "CAPSULES DE PANCRÉLIPASE",
    "en_ingredients": "LIPASE\r\nAMYLASE\r\nPROTEASE",
    "fr_ingredients": "Lipase\r\nAmylase\r\nProtéase",
    "drug_strength": "10000UNIT\r\n40000UNIT\r\n35000UNIT",
    "drug_dosage_form": "CAPSULE (IMMEDIATE RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération immédiate)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100CAP",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 123442,
    "drug": {
      "current_status": "MARKETED",
      "id": 23102,
      "drug_code": 85688,
      "updated_date": "2025-05-15T02:33:02-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258343,
          "ingredient": {
            "id": 2138,
            "ingredient_code": 11104,
            "en_name": "ONDANSETRON",
            "fr_name": "Ondansétron"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02371758",
      "brand_name": "MAR-ONDANSETRON",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131120001"
    },
    "created_date": "2020-08-31T20:34:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02371758",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "A04AA",
    "atc_description": "ANTIEMETICS AND ANTINAUSEANTS",
    "anticipated_start_date": "2020-08-31T00:00:00-04:00",
    "estimated_end_date": "2021-01-08T00:00:00-05:00",
    "actual_start_date": "2020-08-31T00:00:00-04:00",
    "actual_end_date": "2021-01-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2021-01-12T13:39:31-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-ONDANSETRON",
    "en_drug_common_name": "ONDANSETRON",
    "fr_drug_brand_name": "MAR-ONDANSETRON",
    "fr_drug_common_name": "Ondansetron",
    "en_ingredients": "ONDANSETRON",
    "fr_ingredients": "Ondansétron",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "10 Tablet",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  }
]